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CHAPTER 1 
 
 
INTRODUCTION 
 
 
CLCs are important chloride channels with poorly understood structure-function  
relations 
Chloride channels and transporters are membrane embedded proteins that permit 
chloride ions to cross the membrane of cells or intracellular organelles.  There are four 
main classes of chloride channels: the Cystic Fibrosis Transmembrane Receptor (CFTR), 
ligand gated chloride channels, such as the GABA receptor, Bestrophins, and CLCs.  
(Suzuki et al., 2006).  Mutations in CFTR give rise to Cystic Fibrosis.  Compounds that 
modify GABA receptor function have been used in treatment of many brain disorders 
(Ticku, 1983).  Mutations in Bestrophins are associated with a rare form of macular 
degeneration, and can lead to blindness (Hartzell et al., 2005).  We will focus our 
attention on the CLC family of chloride channels and transporters, which underlie many 
important physiological processes to be discussed (Jentsch, 2008).   
CLCs are found in organisms ranging from bacteria to humans, and expressed 
throughout the organism (Thiemann et al., 1992; Jentsch et al., 1995; Brandt and Jentsch, 
1995; Steinmeyer et al., 1991; Sasaki et al., 1994).  In mammals, there are nine CLCs:  
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CLC 1-7, CLC-Ka, and CLC-Kb.  Mammalian CLCs have important physiological roles 
such as controlling cell excitability (Wang et al., 2006), transporting chloride through 
epithelial tissue (Uchida, 2000), trafficking of receptors necessary for endocytosis 
(Christensen et al., 2003), and acidification of intracellular vesicles (Stobrawa et al., 
2001; Hara-Chikuma et al., 2005).  Additionally, mutations in human CLC encoding 
genes give rise to muscle (Koch et al., 1992), kidney (Lloyd et al., 1997), and bone 
disorders  (Kornak et al., 2001).  In fact, mutations in CLC-1 are the primary cause of a 
Figure 1: Summary of, for mammalian CLCs,  (from right to left) vesicular vs. plasma membrane 
localization, CLC name, auxiliary β subunit, expression pattern in mammals, function, human 
diseases caused by mutation, and available mouse models.  CLC-1 to 2, Ka and Kb are plasma 
membrane channels, while CLC-3 to 7 are vesicular.  β-subunit indicates auxiliary subunits that 
interact with CLC-Ka, CLC-Kb, or CLC-7.  Mouse model indicates the phenotype due to knockout 
of the channel, or beta subunit (indicated in red).  Figure taken from Jentsch TJ. Crit Rev Biochem 
Mol Biol. 2008 
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muscle disease called myotonia (Koch et al., 1992).  Figure 1 summarizes the function of 
and diseases caused by mutation of mammalian CLCs. These observations underscore the 
essential roles of CLCs in normal and pathological physiology.   
Many of the aforementioned human disease associated mutations have been found 
in the intracellular portion of CLCs (Pangrazio et al., 2010; Tosetto et al., 2009).  A 
central question in the CLC field is, thus, how do intracellular processes regulate channel 
or transporter function.  My research has addressed this question by furthering an 
understanding of structural mechanisms by which the intracellular domain of CLCs 
regulate CLC gating.  I have approached this question using electrophysiology and 
model-driven mutagenesis in the C. elegans CLCs, CLH-3a and CLH-3b.  These two C. 
elegans CLCs offer clear advantages for deciphering structure-function relationships.  
Additionally, many such structural and physiological characteristics of CLCs have been 
conserved over hundreds of millions of years of evolution, making my C. elegans studies 
relevant to mammalian CLCs (Dutzler et al., 2003; Estevez et al., 2003; Meyer and 
Dutzler, 2006; Markovic and Dutzler, 2007; Meyer et al., 2007; Engh and Maduke, 2005; 
Lin and Chen, 2003; Rutledge et al., 2001; Dutzler et al., 2002).  
 In this introduction, I will provide an overview of CLCs’ essential physiological 
roles as channels and transporters, the C. elegans model system we use, namely CLH-3a 
and CLH-3b, and CLC structure function.  The last item includes pore structure and 
associated gating mechanisms as well as Cystathionine-β-Synthase domain structure and 
physiological roles.   
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CLCs comprise a family of channels and transporters with essential physiological 
roles 
CLCs are anion conducting channels and transporters 
The CLC family of proteins include both voltage gated channels and transporters 
(Zifarelli and Pusch, 2007).  Transporters carry multiple ion species across the 
membrane, while channels only carry one type of ion.  Initially, all CLCs were assumed 
to be channels.  However, electrophysiological experiments showed that, for some CLC 
channels, gating is dependent on pH in a manner that could be explained by CLCs also 
transporting H+ (Accardi and Miller, 2004).  Local pH changes within the cell also 
suggested that some CLCs transport H+ (Picollo and Pusch, 2005).  Of the nine 
mammalian CLCs, CLC-1, 2, Ka, and Kb are Cl- ion channels, while CLC-4 and 5, and 
possibly 3 are H+/Cl- antiporters (Zifarelli and Pusch, 2007) with a 2Cl-/1H+ stochiometry 
(Zifarelli and Pusch, 2009a).  CLC-3 to CLC-7 are largely expressed intracellularly, 
while the other CLCs, which are channels, are largely expressed on the plasma membrane 
(Zifarelli and Pusch, 2007)(Figure 1).  The similarity of CLC channels and transporters is 
underscored by the fact that a point mutation of a single residue in a prokaryotic CLC 
transporter, CLC-ec1, can make it function as a constitutively active channel (Accardi 
and Miller, 2004).  
CLCs are anion channels or transporters that are more permeable to Cl- than other 
anions. Certain anions can either permeate the CLC channel or block it, depending on the 
CLC family member.  These anions, which include: F-, Br-, I-, SCN-, NO3-, and CH3SO3-, 
permeate or block by binding to 
 
anion specific binding sites in the pore (Fahlke, 2001).  
These sites have a stronger binding affinity for larger or multi-atom ions (e.g. I-, SCN-, 
NO3-) as opposed to small single-atom ions (e.g. F-, Cl-).  Usually, the ions with stronger 
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binding affinity, which is to say larger ions, are less permeable.  Nonetheless, CLCs vary 
in terms of the most permeable anion.   This lack of consistency in terms of permeation 
preference is generally not seen in cation channels.  This difference has been suggested to 
be due to there being more types of single ion cations than anions in the body, and thus 
selectivity could be more critical  in cation channels (Fahlke, 2001). 
 
 
CLC mutations lead to myotonia, osteopetrosis, and renal disorders  
CLC mutations lead to myotonia (Koch et al., 1992), osteopetrosis (Kornak et al., 
2001), and renal disorders (Jeck et al., 2000; Wolf et al., 2003; Konrad et al., 2000; 
Simon et al., 1997; Lloyd et al., 1996; Barlassina et al., 2007). Myotonia is characterized 
by delayed muscle relaxation and is due to impaired function of CLC-1, the “muscle” 
CLC.  CLC-1 conduction represents ~70% of plasma membrane conductivity in muscle 
cells.  CLC-1 steady state current is an outward rectifier, meaning Cl- only enters the cell 
at steady state, and this results in hyperpolarization of the cell.  Cl – entering the cell is 
considered outward current because of the negative charge of Cl-, and thus the inward 
flow of positive charge.  It is estimated that an 80% reduction in muscle chloride 
conductance will lead to myotonia by increasing excitability of muscle cells.  Over 120 
mutations in CLC-1 have been identified to be associated with either dominant congenital 
myotonia (Thompsen’s Disease) or recessive generalized myotonia (Becker myotonia).  
(Lossin and George, Jr., 2008). 
Osteopetrosis is a disease of bone hardening that can result from disruption of 
CLC-7 function (Kornak et al., 2001).  It characterized by dense, fragile bones lacking 
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bone marrow, and leads to blood cell formation outside the bones (Zhao et al., 2009).  An 
acidic pH is necessary between the bones and osteoclasts (cells that decrease bone mass) 
for proper dissolving of inorganic bone material and enzymatic breakdown of bone 
matrix.  CLC-7’s function as an H+/Cl- antiporter is necessary for maintaining acidic pH 
in this space (Zhao et al., 2009). 
The renal disorders Bartter’s syndrome and Dent’s disease are associated with 
mutations to CLC-Kb (Jeck et al., 2000; Wolf et al., 2003; Konrad et al., 2000; Simon et 
al., 1997) and CLC-5 (Grand et al., 2009; Brakemeier et al., 2004; Yamamoto et al., 
2000; Cox et al., 1999; Igarashi et al., 1998), respectively.  Three CLC proteins, CLC-Ka, 
CLC-Kb and ClC-5, and an accessory subunit, Barttin, are mainly expressed in the 
kidney (Sasaki et al., 1994; Steinmeyer et al., 1995).  These CLCs function in 
concentration of urine, salt transport through epithelia, and acidification of endosomes 
(Plans et al., 2009).  
Dent’s disease is characterized by the presence of low molecular weight proteins 
in the urine.  Normally, such proteins are reabsorbed by receptor-mediated endocytosis in 
the proximal tubule.  However, CLC-5 function disruption in Dent’s disorder leads to 
defects in endocytosis, which can lead to the proteins not being reabsorbed.  CLC-5’s role 
in endocytosis comes from the fact that endocytosis require proper vesicle acidification in 
order for receptor proteins to bind ligands.  Such acidification could be mediated by 
CLC-5’s function as a H+/Cl- antiporter (Plans et al., 2009).   
Bartter’s syndrome is characterized by dehydration and improper salt 
concentrations in urine.  CLC-Ka’s chloride transporting ability is necessary for 
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maintaining the concentration gradient along the Loop of Henle, which allows for 
concentration of urine.  Thus, CLC-Ka dysfunction leads to excessively dilute urine and, 
thus, diabetes insipidous, as reported in mice (Matsumura et al., 1999).  Such fluid loss 
could contribute to dehydration.  CLC-Kb, on the other hand, is necessary for tubular 
reabsorption of Cl- and other ions along the distal tubule.  CLC-Kb dysfunction, therefore 
would lead to the excessive salt loss associated with Bartter’s syndrome (Wolf et al., 
2003). 
 
 
C. elegans and their CLCs are an ideal model system with physiological relevance to 
mammals 
C. elegans, with six CLC encoding genes, is a useful model system 
We use the C. elegans CLCs, CLH-3a and CLH-3b, as a model system for our 
structure-function studies.  The C. elegans genome contains six CLC-encoding genes, 
clh-1 to clh-6, (for Cl− channel homolog) (Schriever et al., 1999) which have homologs 
of the members of the three subfamilies of mammalian CLCs (Waldegger and Jentsch, 
2000).  These subfamilies are the CLC channels (CLC-0 to CLC-2, CLC-Ka and CLC-
Kb), the CLC transporters (CLC-3 to CLC-5) and the third subfamily containing CLC-6 
and CLC-7. 
The C. elegans genes encode chloride channels that are expressed throughout the 
C. elegans, as delineated here (Nehrke et al., 2000). clh-1 is expressed in neurons, 
epithelia, intestinal, reproductive cells, and cells involved with cuticle formation called 
seam cells. Clh-2 is expressed in neurons, body wall muscles, and intestines.  Clh-3 is 
expressed in excretory cells, intestinal epithelia, defecation muscles, and the 
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hermaphrodite-specific neurons (C. elegans are almost always hermaphrodites) 
(Schriever et al., 1999). Clh-4 is expressed in the excretory cells alone.  Clh-5 and clh-6 
are expressed in many cells, though clh-6 is mostly in non neuronal cells (Nehrke et al., 
2000).  Of these genes, only clh-1 and clh-3 encode proteins of known function.  
Specifically, clh-1 disruption results in a nematode with increased body width (Petalcorin 
et al., 1999).  Clh-3, our focus, is activated during meiosis and is sensitive to cell volume 
(Rutledge et al., 2001).  
Our lab first started understanding CLCs through the C. elegans channels in part 
because of the ease of RNAi in C. elegans (Timmons et al., 2003).  For whole animal 
knockdown, C. elegans can simply be fed or, in a more controlled manner, injected 
double stranded RNA, and this leads to loss of function of the corresponding protein 
throughout the worm (Timmons et al., 2003).  Injection in mammals can be quite 
complicated (Lieberman et al., 2003) and was not an established method (Kawakami and 
Hashida, 2007) at the time of our initial study (Rutledge et al., 2001).  C. elegans 
injection, on the other hand, is a relatively straightforward procedure, when compared 
with mammalian injection (Dudley and Goldstein, 2005).  
 
 
CLH-3b is volume sensitive and activated during meiotic maturation in the oocyte 
In an effort to understand cell volume regulation, local injection of RNAi was 
used to identify the molecular basis of an inwardly rectifying volume sensitive chloride 
current.  This current, in the C. elegans oocyte, was determined to be carried through a 
CLC protein encoded by clh-3 (Rutledge et al., 2001).  Clh-3 has two splice variants: 
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CLH-3a and CLH-3b (Denton et al., 2004).  The pH and volume sensitivity of CLH-3b 
are consistent with that of the volume sensitive oocyte current (Rutledge et al., 2001; 
Rutledge et al., 2001; Denton et al., 2004).  Additionally, the CLH-3b protein was found 
to be expressed in the C. elegans oocyte (Denton et al., 2004).  Thus, the volume-
sensitive oocyte current is carried through CLH-3b. 
The physiological signal for CLH-3b activation, however, is not volume 
regulation, but rather a process called meiotic maturation in the oocyte (Rutledge et al., 
2001).  In reproduction, oocytes arrest during prophase of meiosis.  Meiotic maturation is 
the process by which oocytes continue onto metaphase after this temporal arrest, and is 
triggered by a hormonal signal from the sperm.  During the time of meiotic maturation, 
the nuclear envelope breaks down, the cytoskeleton rearranges, and the meiotic spindle 
forms.  Meiotic maturation leads immediately to ovulation, fertilization, and zygote 
formation.  Ovulation requires repetitive contraction of muscles in the C. elegans called 
gonadal sheath cells (Greenstein, 2005).  Clh-3 knockdown via RNAi leads to these 
contractions initiating sooner (Rutledge et al., 2001).   
Cell cycle processes, such as meiotic maturation, are regulated by the same class 
of enzymes as those that confer CLH-3b’s volume sensitivity.  Specifically, the cell cycle 
phosphatases CeGLC-7 α and CeGLC-7 β activate CLH-3b during cell swelling 
(Rutledge et al., 2002; Dan et al., 2001), while Germinal Center Kinase (GCK)-3 of the 
Ste20 family deactivates CLH-3b and inhibits such activation.  Besides deactivation, 
GCK-3 affects biophysical properties of CLH-3b (Denton et al., 2005).  Ste20 kinases are 
involved in cell cycle processes such as cell growth, differentiation, and death (Pombo et 
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al., 2007).  Similar regulation is found in mammals:  a Ste-20 kinase, PASK, regulates the 
volume sensitive Na-K-Cl cotransporter, NKCC1 (Dowd and Forbush, 2003; Gagnon et 
al., 2006). 
This link between cell volume regulation and cell cycle progression is certainly 
not limited to CLH-3b.  Indeed, periodic cell cycle events, such as S-phase DNA 
replication and mitosis are triggered by the cell reaching a critical size (Mitchison, 2003).  
Similarly, apoptotic cell death is preceded by a type of cell shrinkage termed Apoptotic 
Volume Decrease.  This volume decrease, and the subsequent apoptosis, is prevented by 
blocking volume-regulatory K+ or Cl- channels (Maeno et al., 2000). 
Regulatory volume decrease is a type of volume regulation where swelling 
diminishes after hypotonicity is maintained for extended time periods.  Proteins encoded 
by clh-3 do not play a role in such volume regulation. That is, they do not affect the 
magnitude of volume increase or regulatory decrease due to hypotonicity (Rutledge et al., 
2001). 
Additionally, based upon their voltage sensitivity and expression patterns, it is 
possible that CLH-3a functions during electrical activity in muscles and hermaphrodite 
specific neurons, while CLH-3b functions during Cl- transport in non-excitable cells 
(Denton et al., 2004).  This is because CLH-3a activates at more negative voltages than 
CLH-3b.  Additionally, this activation in CLH-3a is potentiated by prior positive holding 
voltages.  Such potentiation could be physiologically relevant during action potentials or 
periods of depolarization followed by hyperpolarization.  C. elegans neurons generally 
lack action potentials (Goodman et al., 1998), although recent reports suggest that some 
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C. elegans neurons may use action potentials (Lockery et al., 2009; Mellem et al., 2008).  
Nonetheless, C. elegans neurons do show a wide range of membrane voltages and a 
relatively large, though graded, change in potential due to small electrical stimulus.  
Specifically, the membrane potential of C. elegans neurons varies in the range of –30 to –
90 mV, a range where CLH-3a’s potentiation could start to become physiological 
(Goodman et al., 1998; Denton et al., 2004).  C. elegans enteric muscles, which express 
clh –3, do exhibit action potentials (Lee et al., 1997; Davis et al., 1995).  These action 
potentials have relatively long Ca++ channel dependent depolarizations (Lee et al., 1997), 
which could be affected by CLH-3a’s potentiation.  
 
 
Electrophysiology Basics: Current represents the number of open cell-surface 
channels 
We use electrophysiology, specifically the whole cell configuration, to assess 
channel function.  We patch onto green fluorescent HEK 293 cells that have been 
transfected with channel plasmids and GFP.  In the whole cell electrophysiology setup, 
the inside of the cell is electrically connected to a voltage-clamp amplifier.  This 
amplifier injects current into the cell, as necessary, to maintain constant voltage across 
the cell membrane. The magnitude of this current relates to the number of open channels, 
as I will explain.  
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The injected current necessary to maintain constant voltage can be determined 
from a form of ohms law: 
 Current injected  = Membrane voltage * Conductance across cell membrane 
As this shows, with voltage maintained constant, current injected is proportional 
to conductance across the membrane.  Conductance, and thus current, is a measure of the 
number of channels that are on the cell surface and open.  Conductance is also affected 
by the unit conductivity of each channel.  However, this rarely changes and, for CLH-3b, 
is believed to be too small to measure.   
The following terms are often used in electrophysiology.  “Membrane potential” 
or “membrane voltage” refers to the voltage difference between the inside and outside of 
the cell.  “Hyperpolarization”, often caused by a “hyperpolarizing current”, is a decrease 
in membrane voltage, making the voltage across the membrane more negative or less 
positive.  “Depolarization”, often caused by a “depolarizing current”, is an increase in 
membrane voltage, making the voltage less negative or more positive.   
 
 
With clear gating & sequence differences, CLH-3a and CLH-3b are an excellent 
model system for structure-function studies  
My studies use CLH-3a and CLH-3b as a model system to understand structure-
function relationships in CLCs. As splice variants, CLH-3a and CLH-3b have localized 
 differences in sequence of the N- and C- termini, shown in Figure 2 (Denton et al., 2006; 
He et al., 2006).  The intramembrane domains of CLH-3a and CLH-3b are completely 
identical.  The major differences in sequence of the channels are a 71 amino acid 
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extension at the N-terminus of CLH-3a, a 160 amino acid extension at the C-terminus of 
CLH-3b and an insertion of 101 amino acids in CLH-3b between two structural domains 
called Cystathionine−β-Synthase domains (Bateman, 1997) (CBS1 and CBS2) (Denton et 
al., 2006; He et al., 2006).  In addition, eight of the last nine amino acids of CLH-3a are 
distinct from their corresponding amino acids in CLH-3b (Denton et al., 2004).  These 
localized differences in sequence are one of three reasons that the splice variants make 
excellent model systems for structure-function studies.   
 
 
 
 
 
 Another reason for using the splice variants is their striking differences in channel 
gating.  While both CLH-3a and CLH-3b activate in response to hyperpolarizing negative 
voltages, CLH-3a has a more negative activation voltage (Figure 3A) and shows 
increased sensitivity to extracellular Cl- (Figure 3B) and pH (Figure 3C) (He et al., 2006; 
Denton et al., 2004).  Specifically, lowering the external [Cl-] deactivates CLH-3a, while 
Figure 2: Diagram illustrating sequence difference between the clh-3 splice variants CLH-3a and CLH-3b.  
Grey regions are identical; blue regions are unique to CLH-3a; red regions are unique to CLH-3b.  CBS 
refers to the structural domain called Cystathionine-β-Synthase domains.  The figure shows sequence 
differences between the splice variants are localized and at the N- and C- termini.  The major differences 
in sequence are a 71 amino acid extension at the N-terminus of CLH-3a, a 160 amino acid extension at the 
C-terminus of CLH-3b and an insertion of a 101 amino acid motif in CLH-3b between CBS1 and CBS2.  
In addition, eight of the last nine amino acids of CLH-3a are distinct from their corresponding amino 
acids in CLH-3b and there is one distinct residue, besides the 101, between CBS1 and CBS2.  
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it has virtually no effect on CLH-3b activation.  Additionally, acidic pH of 5.9, as 
compared to pH 7.4, activates CLH-3a by ~3-fold, while it activates CLH-3b by only ~ 
1.6-fold.  Most strikingly, CLH-3a exhibits sensitivity to prior depolarizing voltages, 
termed “prepotentiation”, mentioned earlier.  That is, holding resting membrane potential 
at positive voltages prior to hyperpolarizing activation increases channel current induced 
by the subsequent hyperpolarized voltages (Denton et al., 2004; He et al., 2006) (Figure 
3D).  Moreover, previous studies have shown that mutations to CLH-3a or CLH-3b 
always had gating that closely resembled one of the two splice variants (Denton et al., 
2006; He et al., 2006).  In other words, novel or intermediate gating was not seen.  
Finally, CLH-3b’s close functional and sequence homology to the mammalian 
CLC-2 (Rutledge et al., 2001), along with the general conservation of CLC structure 
(Dutzler et al., 2003; Dutzler et al., 2002; Estevez et al., 2003; Engh and Maduke, 2005; 
Lin and Chen, 2003; Meyer and Dutzler, 2006; Markovic and Dutzler, 2007; Meyer et al., 
2007), make CLH-3b structure-function likely to be applicable to mammals.  Much like 
CLC-2, CLH-3a and CLH-3b are inward rectifiers, only allowing Cl- to leave the cell (Cl- 
is negative; thus the flow of charge is inward) (Rutledge et al., 2001; Denton et al., 2004).  
CLH-3a, CLH-3b, and CLC-2 all activate in response to hyperpolarizing stimulus 
(Rutledge et al., 2001; Denton et al., 2004), and CLH-3b and CLC-2 both activate by cell 
swelling (Rutledge et al., 2001).  In short, gating of CLH-3b closely resembles that of 
CLC-2.  
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To summarize, the localized sequence differences, strikingly distinct and discrete 
gating, and relevance to mammalian physiology make CLH-3a and CLH-3b useful tools 
for elucidating relationships of CLC structure and function.   
 
Figure 3: CLH-3a and CLH-3b exhibit clear differences in channel gating. A. CLH-3a requires 
hyperpolarization to more negative voltages to activate. B. CLH-3a is more sensitive to external [Cl-]. Plot 
show ratio of current at -100mV with 12mM external [Cl-] to current at -100mV with 92 mM external [Cl-]. 
Deviation from one indicates increased sensitivity. C. CLH-3a has increased sensitivity to external pH. Plot 
shows ratio of current with external pH 5.9 to current with external pH 7.4 D. CLH-3a is sensitive to positive 
holding voltages (i.e. exhibits prepotentiation), while CLH-3b is insensitive. First, a three second 
depolarized holding voltage between -20 and + 60 was applied, during which channels were closed.  Next, 
for three seconds, voltage was dropped to -120 mV and sample recorded currents are shown. Five traces 
indicate five different holding voltages.  For CLH-3b all five traces coincide, thus CLH-3b is insensitive to 
positive holding voltages.  For CLH-3a more positive holding voltage potentiates channel current.
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CLC structure-function relations are known in the pore, but not cytoplasmic, region 
CLCs are homodimers with a conserved alpha-helical membrane region 
Crystal structures have been solved for bacterial CLCs (Dutzler et al., 2002; 
Dutzler et al., 2003) and the cytoplasmic region of eukaryotic CLCs (Meyer and Dutzler, 
2006; Markovic and Dutzler, 2007; Meyer et al., 2007).  All CLCs are homodimers with 
a single pore per monomer (Figure 4A).  Each monomer consists of 18 alpha helices, A-
R, 17 of which are intramembrane (Figure 4B).  In eukaryotic and some prokaryotic 
CLCs, each monomer also has a large cytoplasmic region containing two Cystathionine-
β-Synthase (CBS) domains (Bateman, 1997) per monomer (Meyer and Dutzler, 2006; 
Markovic and Dutzler, 2007; Meyer et al., 2007) (Figure 4B).  CLC membrane structure 
is likely to be conserved in organisms ranging from bacteria to humans (Dutzler et al., 
2003; Dutzler et al., 2002; Estevez et al., 2003);(Engh and Maduke, 2005; Lin and Chen, 
2003), and CLC cytoplasmic structure is likely conserved among eukaryotes (Meyer and 
Dutzler, 2006; Markovic and Dutzler, 2007; Meyer et al., 2007).  Thus, C. elegans CLC 
structure function studies are highly applicable to mammalian CLCs.   
 
 
CLCs have a “slow” gate common for both subunits and two individual “fast” gates  
The crystal structures of the membrane region of bacterial CLCs have provided 
insights into channel gating mechanisms.  CLCs have a “slow” gate and two “fast” gates 
(Dutzler et al., 2002; Dutzler et al., 2003; Ludewig et al., 1996), named after their 
opening kinetics.  The slow gate acts on both pores simultaneously and is also called a 
“common” gate.  The fast gates are individual to each pore (Figure 4A).  
 17 
 
 
 18 
The currents through fast vs. slow gates can usually be distinguished by analyzing 
opening kinetics of CLCs electrophysiological traces.  We will take the trace of CLH-3b as an 
example.  CLH-3b opens in the millisecond time range in response to negative voltages and does 
not deactivate (Denton et al., 2004; He et al., 2006).  The opening kinetics of CLH-3b, as well 
as many CLCs, can be fitted with two exponential time constants.  The current fitting to 
the faster time constant (~ 5 ms for CLH-3b) (Denton et al., 2004) is defined to be 
through the fast gate, while the current fitting the slower time constant (~ 20 ms for CLH-
3b) (Denton et al., 2004) is defined to be controlled by the slow gate.  In the case that 
exponential fits cannot resolve the separate current components, one can measure the 
component due to slow gating by blocking slow gating with Zn++ (Chen, 1998) or using 
special voltage protocols (Yusef et al., 2006).  In some (de Santiago et al., 2005; Yusef et 
al., 2006), but not all (Miller, 1982), CLCs the fast and slow gate are believed to be 
coupled. 
 
 
Fast gating is controlled by the glutamate gate, while slow mechanisms are not 
understood  
The fast gate structure can be understood in detail from the membrane structure of 
bacterial CLCs.  Four of the seventeen membrane helices, D, F, N, and R, converge to 
form the fast gate, channel pore, and selectivity filter in CLCs (Dutzler et al., 2002; 
Dutzler et al., 2003). The fast gate, itself, is an extracellular glutamate residue located on 
helix F, and is also called a “glutamate gate” (Dutzler et al., 2003; Dutzler et al., 2002). 
Mutation of the fast gate in various CLCs is known to abolish all sensitivity of the 
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channel to voltage, external pH, and external [Cl-] (Traverso et al., 2003; He et al., 2006; 
Traverso et al., 2006; Dutzler et al., 2003; Yusef et al., 2006). 
As such, the fast gates in CLCs underlie their sensitivity to negative membrane 
voltages, acidic pH, and high external [Cl-].  In general, opening and closing of the fast 
gate involves a minor change in orientation of just the negatively charged glutamate gate 
(Dutzler et al., 2003; Dutzler et al., 2002).  In the closed state, the negative oxygens of 
the glutamate residue displace the chloride ion (Figure 5A).  The Cl- ions are held in 
place at the pore by polar hydroxyl groups of a serine and a tyrosine, as well as a polar 
amide nitrogen of the main chain (Dutzler et al., 2003).   
Mechanisms have been postulated for how voltage, pH, and external Cl- regulate 
the fast gate.  CLC channels have a voltage sensor unlike any other family of channels: 
the permeant chloride ions themselves confer the voltage sensitivity (Pusch et al., 1995).  
Specifically, it is believed that the permeating chloride ions are repelled by negative 
internal voltage, and this ion movement displaces the fast gate, which results in further 
channel opening (Pusch et al., 1995) (Figure 5B).  An important part of this gating 
mechanism is the fact that there are three Cl- binding sites in the pore (Dutzler et al., 
2002; Dutzler et al., 2003), and thus, binding of one Cl- ion influences binding of other 
Cl- ions (Pusch et al., 1995). In the case of activation by acidic pH, electrophysiological 
studies (Zifarelli et al., 2008; Bisset et al., 2005) suggest that the glutamate gate is 
protonated by low pH, thereby loosing its negative charge, and is no longer held closed 
by coordination with residues in helices D, N, and R (Figure 5C).  For high external [Cl-], 
it has been proposed that the negative external chloride ions may be competing with the 
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glutamate gate for the pore, thereby holding it in open position (Zifarelli et al., 2008; 
Bisset et al., 2005) (Figure 5D).  Mutation of the glutamate gate to alanine results in loss 
of the negatively charged oxygen, and thus the gate is not likely to be held closed (Figure 
5E).  All of these proposed mechanisms involve only the fast gate, although the slow gate 
is also activated by negative voltage, acidic pH, and high external [Cl-] (Rychkov et al., 
1996).   
As of yet very little is known regarding mechanisms of slow gating.  Opening the 
slow gate is believed to require large conformational changes, according to Fluorescence 
Resonance Energy Transfer (FRET) studies (Bykova et al., 2006) and temperature 
sensitivity of channel currents (Zuniga et al., 2004; Ludewig et al., 1997; Bennetts et al., 
2001).  Specifically, FRET studies (Bykova et al., 2006) showed that upon closing the 
slow gate, the distance between cytoplasmic C-termini increased.  The temperature 
sensitivity studies (Zuniga et al., 2004; Bennetts et al., 2001) show the slow gate function 
has a high temperature sensitivity, as compared to the fast gate.  This high temperature 
sensitivity points to a large conformational rearrangement during slow gating (Pusch et 
al., 1997).  Slow gate currents in CLCs are also known to be blocked by Zn++(Chen, 
1998). Based on this Zn++ sensitivity, it is believed that the prepotentiation gating in 
CLH-3a (discussed earlier) is carried through the slow gate (Denton et al., 2004).  
Electrophysiological and mutagenesis studies in CLCs have suggested the cytoplasmic 
region (Fong et al., 1998), including Cystathionine-β-Synthase (CBS) domains (Estevez 
et al., 2004; Yusef et al., 2006), may be an important structural element involved in slow 
gating.   
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Figure  5: Proposed mechanism for CLC fast gate activation.  A. At neutral pH, the oxygen of the glutamate 
residue in the fast gate is deprotonated. Thus, it can co-ordinate with positive residues in the membrane 
helices (aD, aN, and aR) and close the channel.  B. Negative internal voltage repels the Cl- ion, causing it to 
displace the glutamate (fast) gate. C. Acidic pH protonates the oxygen of the glutamate residue, thereby 
neutralizing its charge and freeing it from coordination with helices. D. External chloride ions compete with 
the oxygen of the glutamate gate, thereby holding the gate open. E. Mutation of the glutamate gate to alanine
(side chain is CH3) removes the negative charge, prevents coordination with the helices and, thus, makes the 
channel constitutively open.  
αR
Cl-
αD
αFαN +
+
+
Fast Gate
O- +++
A
- - -- - -- - -- - -- - -
Negative Voltage
αR
Cl-
αD
αFαN +
+
+
O-
+
+
+
Fast Gate
B
αR
Cl-
αD
αFαN +
+
+
OH
+
+
+
Acidic pH
Fast Gate
C
D E
Open States
Closed State
 
 22 
 
CBS domain’s tertiary, but not quaternary, structure is conserved 
CBS domains are found in over a 1000 different types of proteins (Scott et al., 
2004) (predicted by SMART) (Schultz et al., 1998), and have a variety of functions.  
CBS domains are 50-60 amino acids in length, and they consist of two alpha helices (α1 
and α2) and three beta strands (β1-3) in the order β1-α1-β2-β3-α2 (Figure 6A).  There are 
crystal structures for CBS domains in proteins as diverse as AMPK (Jin et al., 2007) (Day 
et al., 2007), IMPDH (Zhang et al., 1999), a theoretical cystathionine-β-synthase 
domain containing protein (Miller et al., 2004), a Mg2+ transporter (Hattori et al., 2007) 
and three CLCs (Markovic and Dutzler, 2007; Meyer and Dutzler, 2006; Meyer et al., 
2007).  In all known CBS domain structures, CBS 1 and 2 exist as pairs that interact at 
the surfaces of β2 and β3 to form a dimer (Figure 6B and C).  These pairs of CBS 
domains often dimerize with other CBS domain pairs to form quaternary structure.  
While the structure of the CBS1-CBS2 pair is conserved, the quaternary structures of 
CBS domains vary (Jin et al., 2007; Meyer and Dutzler, 2006; Markovic and Dutzler, 
2007; Meyer et al., 2007; Hattori et al., 2007; Day et al., 2007; Zhang et al., 1999; Miller 
et al., 2004).   
Crystal structures and biochemical data demonstrate that the cytoplasmic regions 
of CLC-0, CLC-5 and CLC-Ka have a dimeric quaternary structure, with each monomer 
containing two CBS domains (Meyer and Dutzler, 2006; Markovic and Dutzler, 2007; 
Meyer et al., 2007) (Figure 6B and C).  In CLCs, the cytoplasmic monomers interact at a 
90-degree angle.  The interface is formed by CBS2 α1 and other regions of CBS2 of each  
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monomer.  In non-CLC CBS domain containing proteins, monomers either associate in 
parallel “head-to-head’” (CBS1 with CBS1 and CBS2 with CBS2) or “head-to-tail” (each 
CBS1 with the other CBS2) configurations.  Thus, the quaternary structure of CBS 
domains in CLCs is  unique among CBS domain containing proteins (Jin et al., 2007; 
Figure 6: Structure of CBS domains in CLCs.  A. CBS domains are defined by the secondary structure 
pattern: β1-α1-β2-β3-α2. B. Interactions between CBS domains in the cytoplasmic region of CLCs. 
CBS1 and CBS2 interact to form a pair in each CLC monomer. These pairs then interact with the CBS 
domain pair of the other monomer, at CBS2, to form quaternary structure.  Dashed lines indicate 
interactions. C. Crystal structure of the cytoplasmic region of CLC-Ka, indicating conserved 
arrangement of CBS domains.  CBS1 and CBS2 of each monomer interact at β2 and β3, and CBS2 of 
separate monomers interact at α1. 
 24 
Meyer and Dutzler, 2006; Markovic and Dutzler, 2007; Meyer et al., 2007; Hattori et al., 
2007; Day et al., 2007; Zhang et al., 1999; Miller et al., 2004).   
 
 
Cystathionine-β-Synthase (CBS) domains have a wide variety of essential functions 
CBS domains have many different functions, in accord with the wide variety of 
proteins in which they are found.  Mutations in human CBS domains give rise to cardiac 
(Oliveira et al., 2003), metabolic (Shan and Kruger, 1998), retinal (Kennan et al., 2002), 
and muscle disorders (de Diego et al., 1999; Sasaki et al., 1999).  Mutations in CBS 
domains also alter protein trafficking (Pena-Munzenmayer et al., 2005; Bateman and 
Kickhoefer, 2003; Carr et al., 2003), energy metabolism (Scott et al., 2004; Janosik et al., 
2001), protein multimerization (Jhee et al., 2000), binding of ligands (Scott et al., 2004; 
Jin et al., 2007; Day et al., 2007; Meyer et al., 2007; Tanaka et al., 2007), and ion channel 
gating (Bennetts et al., 2007; Lin et al., 2006; Denton et al., 2006; Wu et al., 2006; He et 
al., 2006; Estevez et al., 2004; Bennetts et al., 2005; Yusef et al., 2006). 
In particular, CBS domains bind ions and adenosyl compounds.  Specifically, 
CBS domains of the MgtE Mg2+ transporter bind Mg2+ ions and may sense intracellular 
Mg2+ concentrations (Hattori et al., 2007). CBS domains in a bacterial organic osmolyte 
transporter called OpuA detect changes in intracellular ionic strength.  This likely occurs 
by non specific association of solute ions with the CBS2 domain and interaction of CBS2 
with negatively charged plasma membrane moieties (Mahmood et al., 2009).  
Additionally, adenosyl compounds such as AMP, ADP, and ATP bind to CBS domain 
pairs of IMP dehydrogenase-2 (Scott et al., 2004), AMP-activated protein kinase (Scott et 
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al., 2004; Townley and Shapiro, 2007; Jin et al., 2007; Day et al., 2007), Cystathionine-β-
Synthase (Scott et al., 2004), ClC-2 (Scott et al., 2004) and ClC-5 (Meyer et al., 2007). 
Such binding occurs in a pocket formed by the interface of CBS1 with CBS2.  Studies by 
Bennetts and colleagues show that ATP can regulate gating in CLC-1 (Bennetts et al., 
2005; Bennetts et al., 2007), possibly by binding to CBS domains.   
CBS domains also regulate trafficking of CLCs.  Specifically, normal endosome 
trafficking of CLC-5 is prevented by disease-associated truncation mutations that disrupt 
CBS2 domain structure (Carr et al., 2003).  Additionally, basolateral, as opposed to apical 
targeting of CLC-2 in certain epithelial cells is governed by a di-leucine motif in CBS2 
(Pena-Munzenmayer et al., 2005).  In short, CBS domains have a variety of important 
cellular functions, yet our understanding of their structure-function relationships is still 
limited. 
 
 
Cytoplasmic regions of CLCs regulate gating, likely through the membrane helix R 
Given that CBS domain mutations in CLCs regulate gating (Bennetts et al., 2007; 
Lin et al., 2006; Denton et al., 2006; Wu et al., 2006; He et al., 2006; Estevez et al., 2004; 
Bennetts et al., 2005; Yusef et al., 2006), the mutations are likely to change the conformation 
of the channel gate.  An important unanswered question in the field is how the 
cytoplasmic region of CLCs can alter structure at the extracellular gate.  There have been 
numerous studies that show mutations of the cytoplasmic CBS domains in CLCs affect 
channel gating (Bennetts et al., 2007; Yusef et al., 2006; Lin et al., 2006; Wu et al., 2006; 
Denton et al., 2006; He et al., 2006; Estevez et al., 2004; Bennetts et al., 2005).  Of 
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significance to our work, studies show that mutations to CBS2 impact gating (Yusef et 
al., 2006; Estevez et al., 2004; Wu et al., 2006) to a larger extent than do mutations to 
CBS1 (Estevez et al., 2004). Mutations in the cytoplasmic region outside the CBS 
domains also affect channel gating (Estevez et al., 2004; Hryciw et al., 1998; Schmidt-
Rose and Jentsch, 1997; Wu et al., 2006; Hebeisen et al., 2004; He et al., 2006; Macias et 
al., 2007).  The importance of CBS domain mutations is further underscored by the fact 
that human CBS mutations associated with myotonia (Lin et al., 2006) and kidney stones 
(Lloyd et al., 1997) also alter channel gating.   
Like in many CLCs, CLH-3a’s and CLH-3b’s gating are regulated by their 
cytoplasmic regions.  The splice variants have clearly different gating and localized 
sequence differences, as discussed earlier and in Figures 2 and 3.  Of these sequence 
differences, our lab has found that the ones leading to the difference in gating are either 
in the CBS domains or in the large 160 amino acid extension following CBS2 in CLH-3b 
(He et al., 2006).  Additionally, changes in the phosphorylation state of CLH-3b due to 
kinases and cell swelling regulate channel gating through an intracellular domain located 
between the CBS domains (Falin et al., 2009; Denton et al., 2005). While it is clearly 
demonstrated in CLCs that the cytoplasmic region, including CBS domains, regulate 
gating, as of yet there is no experimentally demonstrated mechanism for this regulation. 
Dutzler and colleagues (Dutzler et al., 2002) have suggested just such a possible 
mechanism (Figure 7).  The cytoplasmic region is connected to the membrane helix R, 
which is part of the channel pore and selectivity filter (Dutzler et al., 2002).  Thus, the  
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Figure 7: Proposed mechanism for regulation of gating by the cytoplasmic regions.  αN, αF, αR, and αD are 
four membrane helices that make up the fast gate, selectivity filter, and channel pore.  The cytoplasmic
region, including Cystathionine-β-Synthase domains (CBS1 and CBS2), is connected to the channel pore 
through the R helix.  Thus, the R helix may transmit a conformational change from the cytoplasmic region to 
the channel gate.  As of yet, this hypothesized mechanism lacks direct proof.
 
 
mechanism is that Helix R provides a link to transmit a conformational change from the 
cytoplasmic region to the channel pore.  
This hypothesized mechanism and information from crystal structures help 
explain the strong effect of CBS2 mutations on gating.  Specifically, crystal structures 
show CBS2 is in proximity to the N-terminal portion of the cytoplasmic domain, which 
connects CBS1 to the R helix (Markovic and Dutzler, 2007; Meyer et al., 2007; Meyer 
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and Dutzler, 2006).  Dutzler and colleagues (Meyer and Dutzler, 2006) proposed that this 
R helix-CBS1 connector, which we call the “R-Helix linker” may be important for 
transmitting conformational changes.  This suggests a possible structural link between the 
CBS domains and the R Helix, which my thesis will explore.   
 
 
Central question of thesis 
The goal of my dissertation research is to address an important question in the CLC field: 
how do the CBS domains regulate CLC channel gating.  The C. elegans splice variants, 
CLH-3a and CLH-3b offer unique advantages for understanding structure - function 
relationships, given their localized sequence differences and discrete differences in 
channel gating. This gating difference has been found to be due to the cytoplasmic region 
of the splice variants, which includes CBS domains.   
I have tested the hypothesis that splice variation of the CBS domains 
regulates gating differences between CLH-3a and CLH-3b.  My first aim was that 
this regulation was carried through the R Helix linker.  I have approached this 
question using structural homology modeling, mutagenesis, and electrophysiological 
methods.  My work is one of the first studies supporting the involvement of the R helix 
linker in regulation of CLC gating by CBS domains.   
 Mechanisms derived from the C. elegans CLCs are pertinent to mammalian 
CLCs since CLC and CBS domain structure is highly conserved.  Thus, these studies 
shed light onto mechanisms of CBS domain regulation of gating in mammals and an 
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understanding of many human muscle, kidney, and bone diseases associated with 
mutations in CBS domains of CLCs (reviewed in: (Ignoul and Eggermont, 2005)).  In 
short, this work has broad significance related to fundamental mechanisms of CLC 
biology and to human pathology.   
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CHAPTER II 
 
 
HOMOLOGY MODEL OF CLH-3b PREDICTS AN INTERACTION OF THE R-
HELIX LINKER AND α2 OF CBS2 
 
 
Summary 
Homology models allow one to hypothesize intra-protein interactions and thereby 
help elucidate mechanisms for regulation of protein function.  We use homology 
modeling in order to understand mechanisms by which CBS domains alter CLC function.  
We developed homology models for the CBS domains of the splice variants CLH-3a and 
CLH-3b based upon the high resolution and high homology structure of CLC-Ka.  Using 
Rosetta modeling, we predicted the structural difference between CLH-3a and CLH-3b 
CBS domains lies in the length of α2 of CBS2.  In addition to affecting the length of α2, 
the splice variation of CLH-3b is predicted to alter interactions with the R-helix linker.  
The R-helix linker is a set of unstructured amino acids that connects the CBS domains to 
the pore-forming R-helix.  Our model predicts a possible interaction of CLH-3b F559 in 
the R Helix linker with CLH-3b A836 in α2 of CBS2.  A possible functional importance 
of A836 is consistent with results from calculations on the change in stability due to 
mutation of the splice variation.  Further experimental studies are important to 
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experimentally test for the functional importance of the hypothesized α2 / R-helix linker 
interaction. 
 
 
Introduction 
Why use a homology model? 
Homology modeling can provide a useful tool for structure function studies in the 
absence of a crystal structure of the protein of interest.  Specifically, homology modeling 
allows one to develop a putative structure that is based upon the structure of a 
homologous protein.  With this structure, one can postulate possible interactions within 
the protein that may be functionally important and, then, assess the functional effect of 
disrupting such interactions through mutagenesis.   
Homology models of the cytoplasmic region of other CLCs have successfully 
identified mutations that affect channel function and shed light on CLC structure 
function. For instance, Estevez and colleagues used a homology model of CLC-1 CBS 
domains, based on IMPDH, to identify residues that have substantial impact on channel 
gating (Estevez et al., 2004). Martinez and colleagues used a homology model of CLC-
Kb, based on the extremely closely related CLC-Ka, in order to determine the 
arrangement of cytoplasmic monomers in CLC-Kb (Martinez and Maduke, 2008).  CLC 
mutations affecting channel ATP sensitivity have been determined using homology 
modeling combined with electrophysiology (De Angeli et al., 2009) and also modeling 
alongside computational ligand docking (Bennetts et al., 2005). 
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In the CLC I study, particularly CLH-3b, previous work in our lab (He et al., 
2006) has suggested the CBS domains or the 160 C-terminal amino acids (Figure 2) are 
critical for normal channel gating.  To understand how the CBS domains regulate gating, 
I have made a homology model of the CBS domains of CLH-3a and CLH-3b.   
 
 
CLH-3a and CLH-3b are excellent candidates for homology modeling 
Homology models are based on the crystal structure of a carefully chosen 
homologous protein called the template.  Accuracy of the model depends upon the 
template’s resolution and its percent homology with the modeled protein.   
Three possible template structures for CLH-3b are the cytoplasmic regions of 
CLC-0 (Meyer and Dutzler, 2006), CLC-5 (Meyer et al., 2007), and CLC-Ka (Markovic 
and Dutzler, 2007).  The percent homology with the modeled region of CLH-3b and the 
angstrom resolution of these templates are shown in the table below (Meyer and Dutzler, 
2006; Meyer et al., 2007; Markovic and Dutzler, 2007).  CLC-0 was crystallized as a 
cytoplasmic monomer (Meyer and Dutzler, 2006), while CLC-Ka and CLC-5 were 
crystallized in the native cytoplasmic dimeric state (Markovic and Dutzler, 2007; Meyer 
et al., 2007). CLC-Ka has made an excellent template choice for us, given its high 
resolution (1.6A) and high homology to CLH-3b (~50 %), and likely physiological 
dimeric structure (Markovic and Dutzler, 2007).  Such high homology and high template 
resolution tend to yield accurate models.   
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Template % Homology to CLH-3b* Resolution (Å) 
CLC-0 57 3.1 
CLC-Ka 48 1.6 
CLC-5 44 2.3 
*Calculated with Vector NTI (Lu and Moriyama, 2004) 
Table 1: Percent homologies and resolution of templates. Table shows, for each possible 
template of homology model, percent homology with CLH-3b of CBS domains and 
crystal structure resolution.   
 
 
Homology modeling: overview of procedure and theoretical basis. 
Six general steps are used in homology modeling, as I discuss for our CLH-3b 
model.  First, CLC-Ka was chosen as a template for reasons mentioned previously.  Next, 
secondary structure prediction was done on the template and CLH-3b in the region 
modeled.  Third, secondary structure predictions were used to align the sequence of 
CLH-3b and CLC-Ka.  Fourth, the CLH-3b backbone model was predicted by replacing 
each amino acid in the template with its corresponding one from CLH-3b.  Fifth, 
homology modeling software was used to predict the structure of regions of CLH-3b that 
did not correspond to any part of CLC-Ka.  Finally, the side chain orientations were 
predicted.   
The majority of programs we used to predict structures are based upon 
bioinformatics knowledge of all experimental structures.  BCL::Align (Dong et al., 2008) 
alignment software incorporates three secondary structure prediction algorithms (Bradley 
et al., 2003; Meiler and Baker, 2003; Jones, 1999; McGuffin et al., 2000; Karplus et al., 
1998).  The software Modeller (Sali and Blundell, 1993) develops the backbone using 
“spatial restraints” from the template.  Spatial restraints are limitations on parameters, 
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such as distances between adjacent atoms and dihedral angles, which are derived from 
values in the template (Sali and Blundell, 1993).  Modeller predicts the structure of 
regions not aligned to amino acids in the template using theoretical physics principles as 
well as spatial restraints, this time based on many existing protein structures.  The 
program SCWRL (Canutescu et al., 2003) predicts side chain conformation using 
knowledge of common conformations in experimental structures. 
To test our modeling methods, a homology model of CLC-5 based on CLC-Ka 
(PDB Code: 2pfi) (Markovic and Dutzler, 2007) was generated and compared with the 
crystal structure of CLC-5 (PDB Code: 2j9l) (Meyer et al., 2007). 
 
 
Predicting difference in structure between CLH-3a and CLH-3b: length of the α-
helix 2 
Using domain recognition software (Finn et al., 2006; Pagni et al., 2004; 
Quevillon et al., 2005), the CBS domains of CLH-3b were found to span amino acids 561 
to 614 and 791 to 838.  The homologous regions of CLH-3a are 632 to 685 and 761 to 
808.  The only difference in CBS domain sequence between CLH-3a and CLH-3b is the 
last six amino acids of CBS2.  Three amino acids C-terminal to CBS2 are also distinct.  
Preliminary homology modeling suggested that part of these nine amino acids are in α2 
of CBS2, and that α2 may be longer in CLH-3b than in CLH-3a.  As such, Rosetta 
modeling software (Bradley et al., 2003) was used to predict fine differences between the 
length of α2 in the splice variants as well as various CLH-3b mutants. Specifically, we 
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had Rosetta predict, de novo, the structure of the splice variation using the remainder of 
the homology model as a fixed structural context.   
Secondary structure prediction programs were not considered precise enough for 
such predictions of helix length for two main reasons.  For one, the expected difference in 
helix lengths, based on preliminary modeling, were too fine for the accuracy of secondary 
structure predictions.  Second, secondary structure prediction programs only incorporate 
sequence information, while the Rosetta modeling uses information about predicted 
tertiary structure of the surrounding protein for predictions.   
Such de novo predictions with Rosetta can be used for prediction of entire protein 
structures, not just fragments.  The usefulness of de novo predictions is highlighted by the 
fact that the majority of sequences do not have a homologous template.  Additionally, the 
Protein Data Bank database of existing structures does not represent all theoretically 
possible conformations.  De novo predictions can partially compensate for these 
difficulties. 
To calculate structure de novo, Rosetta breaks the protein sequence into three or 
nine amino acid fragments and looks for the structure of the fragment in other existing 
proteins.  The protein structure fragments are selected based upon sequence and 
secondary structure similarity with the predicted fragment and with amino acid in vicinity 
of the fragment.  Three dimensional fit into the remainder of the protein is also 
considered.  The fragments are assembled in various conformations, and a structure is 
chosen using three criteria, in this order: 1. Highly unfolded proteins are eliminated 2.  
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Low energy structures are selected 3. The most representative of the remaining structures 
is chosen (Rohl et al., 2004). 
 
 
Predicted effects of mutation of the splice variation on CBS domain stability 
We also did a computational screen for amino acids in the splice variation that 
may be critical for protein stability, and hence possibly protein function.  Specifically, we 
had Rosetta predict the effect on stability of mutating each of the nine spliced amino 
acids, i.e., LRLAIEYLQ, in CLH-3b to all other amino acids. Such calculations were also 
done to compare the predicted stability of the CBS domains in CLH-3a vs. CLH-3b. 
 “Stability” of a protein is predicted by calculating the stored, i.e. potential, 
energy of the protein.  Since potential energies are always relative, in protein 
biochemistry they are considered to be the energy of the native protein with respect to the 
unfolded polypeptide chain.  This energy is compared for WT and mutant proteins in 
order to assess the effect of mutations on stability.   
Potential energy of folding a protein is equal to the sum of potential energy of 
component non-covalent interactions and disulfide bonds.  These interactions are, from 
strongest to weakest: disulfide bonds (70-100 kcal/mol), hydrogen bonds (2-5 kcal/mol), 
electrostatic forces between charges or dipoles (1-3 kcal/mol), and van der Waals, i.e. 
hydrophobic, forces (<1 kcal/mol) (Dill, 1990).  The energies indicated are the energies 
stored in the interaction.  Point mutations will change these interactions, eliminating 
some of these stored energy components, and forming new interactions which store 
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energy.  Thus, for instance, a point mutation that disrupts just one hydrogen bond would 
be expected to change protein potential energy by ~2-5 kcal/mol.   
The main force contributing to folding of a protein and to its stored energy is 
hydrophobic or van der Waals forces (Dill, 1990).  This is consistent with the dramatic 
effect of solvents on protein stability.  Hydrogen bonds are also essential for folding, 
since they compose secondary structure.  There are two forms of electrostatic forces 
affecting stability: net charge on the entire protein, which tends to be destabilizing, and 
local electrostatic interactions, such as salt bridges, which stabilize a protein.  
Electrostatic forces are not predominant in proteins, and thus they are not believed to 
make a sizable contribution to protein stability (Dill, 1990).  
In our study, estimations of change in stability of proteins were made by 
providing a structure, which was the CLH-3b homology model.  In Rosetta’s method, the 
program replaces amino acids as directed by the mutation and determines the new side 
chain orientations.  For each new side chain, different conformations found in existing 
structures are tested, and the lowest energy conformation is chosen (Kaufmann et al., 
2010).  
There are numerous energy functions detailing methods to compute potential 
energy of folding.  Rosetta has two types of energy functions for protein structure 
prediction, one is for preliminary calculations and the other refined (reviewed in: 
(Kaufmann et al., 2010)).  The preliminary Rosetta function treats side chains as 
centroids and incorporates several factors: solvation, pairing of beta strands, charge and 
polar interactions, and steric clashes.  Van der Waals repulsive forces are taken into 
 38 
account by the steric clash term, which penalizes very short atomic distances.  Van der 
Waals attractive forces are taken into account by modeling the protein’s radius of 
gyration and using the premise that more compact proteins have larger attractive forces 
(Simons et al., 1997a).  The refined function incorporates direct calculation of van der 
Waals forces, solvation, hydrogen bonding, electrostatic interactions, and internal free 
energy of amino acids.  These two functions are used to choose the most favorable 
structure after mutation.  The energy function used for calculating the energetic effects of 
mutations incorporates “implicit” solvation (solvent represented as a dielectric constant), 
van der Waals attractions and repulsions, hydrogen bonds, and charge-charge interaction 
(Kortemme and Baker, 2002).  The functions described are largely knowledge based, 
meaning they derive from experimental information in known structures. 
 
 
Methods 
Homology model 
A homology model for the CLH-3b cytoplasmic C-terminus was generated based 
on the crystal structure of the CLC-Ka C-terminus (PDB code 2pfi).  BCL::Align 
software (Dong et al., 2008) was used to align amino acids 544 – 625 and 783-848 of 
CLH-3b with amino acids 542-681 of CLC-Ka.  BCL::Align is based on a weighted sum 
of gap penalties, the chemical properties of amino acids, PAM (R.M.Schwartz and 
M.O.Dayhoff, 1978), BLOSUM (Henikoff and Henikoff, 1992) and PSI-Blast (Altschul 
et al., 1997) scoring matrices, and three different secondary structure prediction methods  
(Meiler and Baker, 2003; Jones, 1999; McGuffin et al., 2000; Karplus et al., 1998).  The 
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alignment of the amino acids immediately C-terminal to CBS1 and N-Terminal to CBS2 
were adjusted by hand in order to produce the alignment shown in Figure 8.  Modeller 
software (Sali and Blundell, 1993) version 9.3 was used to develop 120 candidate 
structures for CLH-3b.  The structure with the lowest predicted energy (i.e. most stable) 
was chosen and side chain orientations were determined using SCWRL 3.0 software 
(Canutescu et al., 2003).  The model was refined by a 500 step minimization with 
AMBER 9 software (Woods and Case, 2005; Ponder and Case, 2003).  The software was 
checked using the structure validation software Procheck (Laskowski et al., 1993), 
WhatIf  (Vriend, 1990), and Harmony (Pugalenthi et al., 2006). 
 
 
 
Homology models were made, by the same methods, based upon the crystal 
structures of ClC-0 and combined template structural information from both CLC-0 and 
α1β1 β2 β3 α2
550                          560                          570                          580                          590    600                          610          
α1β1 β2 β3 α2
17 amino acid linker17 amino acid linker
167 amino acid linker
790                          800        810                          820              830                         840                     
.                                .                             .                               .                             .                               .       
.                               .                               .                               .                               .                               .                              .                           .    
Figure 8: Amino acid alignment of CLC-Ka and CLH-3b used for developing C-terminus 
homology model.  Secondary structure assignments and CBS domain locations are shown 
for CLC-Ka and are based on its crystal structure (Markovic et al., 2007).  CLC-Ka CBS 
domain secondary structure is denoted  β1−α1−β2−β3−α2. Amino acid numbering is 
based on CLH-3b sequence.   
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CLC-Ka.  The resulting homology models had similar structure to the model based upon 
CLC-Ka (RMSD < 2 Å).  The model based upon CLC-Ka was used for all future analysis 
and calculations.  Parts of this CLC-Ka based model that were not consistent with the 
other two models were removed, to yield a model of the amino acids specified earlier 
(552-615 and 783-841 of CLH-3b).  The same method and template was used to build a 
homology model of CLH-3a, covering amino acids 623-686 and 753-811 and a 
homology of separate CBS domains of CLC-5 (amino acids 588 to 657 and 678 to 743). 
The homology model of CLH-3b was manually docked to CLC-ec1 (PDB code: 
1ots) by optimizing 3-dimensional fit and electrostatic interactions. 
 
 
Predicting difference in structure between CLH-3a and CLH-3b: length of α-helix 2 
To estimate how splice variation or mutations affect α2 helical structure, we used 
Rosetta software (Simons et al., 1997b; Bonneau et al., 2002) and the homology model 
generated by Modeller and SCWRL.  Calculations were done for the cytoplasmic region 
of CLH-3a (amino acids 623-686 and 753-811) and CLH-3b, CLH-3b A836D, CLH-3b 
L835DA836D, and CLH-3b L835KA836K (amino acids 549-615 and 783-841) and for 
the CBS2 domain of CLH-3a (amino acids 753 to 811) and CLH-3b (amino acids 783 to 
841).  Rosetta was used to develop de novo 3,000 or 20,000 candidate structures of amino 
acids 803-811 for CLH-3a and 833-841 for WT and mutated CLH-3b.  We used a 
command of the format: 
 
rosetta.gcc -series aa -protein CLH3  -chain A -relax -looprlx -s WTstructure.pdb 
-loop_file regiontobuild.loops -loop_model -nstruct 3000  -ccd_closure -
loop_farlx -fast_loop_farlx -looprlx_fix_natsc 
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Rosetta calculations were done on proteins that include nine alternatively spliced 
residues: the six C-terminal residues of CBS2 and the three following residues.  The 
structure of the remainder of the modeled region surrounding these nine amino acids was 
included for context and held in a fixed conformation.  For each predicted structure, a 
script counted the number out of the nine spliced amino acids that were predicted to be 
helical.  Then, another script counted the number of structures that had a certain number 
of predicted helical amino acids.   
 
Predicted effects of mutation of the splice variation on CBS domain stability 
The mutlist command was used to calculate the predicted change in stability, 
called ∆∆Gmutation, due to mutation of the nine amino acid splice variation of CLH-3b 
(amino acids 833-841: LRLAIEYLQ) to all amino acids. I used a command of the 
format: 
 
rosetta.gcc -interface -s CLH3.pdb -read_all_chains -mutlist 
listofmutations.mutlist -intout resultfile.intout -repack_neighbors >& mutlist.log 
 
 
Results 
Homology model: Testing modeling methods 
 The separate homology models of CBS1 and CBS2 of CLC-5 were each 
structurally aligned to the experimental crystal structure of the corresponding regions of 
CLC-5 (PDB code: 2j9l).  Both alignments produced RMSD < 2.5 Å (calculated with 
PYMOL, www.pymol.org), which is comparable to the resolution of CLC-5.  This result 
gives an example of the accuracy of our modeling methods.   
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Homology model: Interactions between domains are conserved  
The homology model of CLH-3b shows interfacing surfaces that are consistent 
with the CLC cytoplasmic region crystal structures.  Specifically, in the CLH-3b model, 
the interface of cytoplasmic monomers is found to be at CBS2, in particular α1.  Dutzler 
and colleagues (Marcovic, 2007) demonstrated that interaction of the two L650 of CLC-
Ka monomers form part of the monomer-monomer interface.  The homology model of 
CLH-3a and CLH-3b also suggests there is an interface between the two L780 and two 
L810, respectively, which are homologs of CLC-Ka L650. Thus, the monomer-monomer 
interface is likely to be conserved in CLH-3a and CLH-3b. 
Interfaces within the cytoplasmic monomer are also maintained in the CLH-3b 
homology model.  First, in many CBS domain containing proteins, CBS1 and CBS2 
interact at β2 and β3. Second, Dutzler and colleagues demonstrate, in CLC cytoplasmic 
region structures, the N-terminus of the cytoplasmic region preceding CBS1 is in 
proximity to α2 of CBS2.  These two arrangements are found in the CLH-3a and CLH-3b 
models.   
 
 
Homology model predicts A836 in α2 of CBS2 interfaces with R-helix linker at F559 
The homology model manually docked to the membrane region of CLC-ec1 
(PDB code 1ots) is shown in Figure 9.  The only difference in sequence of the CBS 
domains in CLH-3a vs. CLH-3b is splice variation of 9 amino acids in and following the 
C-terminus of CBS2.  This homology model predicts that the splice variation is part of 
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α2 of CBS2 and includes amino acids C-terminal of α2.  Since this is the only splice 
variation of CBS2, it is likely that these amino acids lead to differences in channel gating.  
Experimental studies to be discussed in chapter III confirm this is the case. Thus, I 
proceeded to analyze the model for interactions of this splice variation.  
 
 
α1
α1
α2
α2
R helix R helix
CBS2
CBS1
R helix linker
Figure 9: Ribbon diagram of CLH-3b C-terminus homology model.  To provide context for the C-terminus 
structure, it is shown manually docked to the CLC-ec1 intramembrane region (gray and magenta; Protein 
Data Bank accession code 1OTS; (Dutzler et al., 2003).  The R-helix of the intramembrane domain is shown 
in magenta and the cytoplasmic R-helix linker is shown in black.  Each monomer of the cytoplasmic C-
terminus dimer contains one CBS1 (red) and one CBS2 (green) domain.  The six amino acid splice variation 
of CBS2 is shown in blue.  The region (amino acids 616-782) between CBS1 and CBS2 is not modeled.  
Also not modeled are the first nine amino acids of the R helix linker.  
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Two observations are readily available, that lead to hypotheses. First, α2 may be 
interacting with the amino acids N-terminal of CBS1, known as the R Helix linker.  The  
strongest predicted interaction of the R helix linker is at F559 interacting with A836 of 
α2 in CLH-3b (Figure 10A). The splice variation may be altering the conformation of the 
R helix linker, which then alters the conformation of the R helix, either by direct 
connection or further interactions. 
Second, α2 may be interacting with α1, which in turn forms the monomer-
monomer interface.  An alteration of the monomer-monomer interface could lead to 
global changes in CLH-3a vs. CLH-3b structure, which could affect channel gating.  
While the model does predict an interaction of α1 with α2, splice variation of α2 is not 
predicted to change interactions at the monomer-monomer interface.  Thus, this 
interaction was not pursued in further detail. 
 
 
Predicting difference in structure between CLH-3a and CLH-3b: length of α-helix 2 
Figure 11A shows a histogram of the predicted number of helical amino acids, of 
the nine, for WT CLH-3a and WT CLH-3b. Figure 11B shows a similar histogram for 
CLH-3b A836D, CLH-3b L835DA836D, and CLH-3b L835KA836K.  The median 
number of helical amino acids, represented by the x-axis value at the peak of the 
histogram, is the most commonly found number of helical amino acids.  This value is 5 
for CLH-3a, 7 for CLH-3b, and 8 for all the CLH-3b mutants CLH-3b A836D, CLH-3b 
L835DA836D, and CLH-3b L835KA836K. This indicates that mutants expected to  
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CLH-3b
CLC-0
CLC-Ka
A
C
B
Figure 10: The CLH-3b F559 of the R helix linker (black) postulated interface with A836 of α2 (green) is 
conserved in crystal structures of CLC-0 and CLC-Ka.  A. CLH-3b F559( red) is predicted to interface with 
CLH-3b A836 (yellow).  B. The CLC-Ka homolog of CLH-3b F559, also a Phenylalanine (red), interfaces 
with an Alanine (yellow) homologous to CLH-3b A836.  C.  The CLC-0 homolog of CLH-3b F559, a 
similarly hydrophobic and bulky Isoleucine (red) interfaces with an Alanine (yellow) homologous to CLH-
3b A836.  
Phe 559
Ile
Phe
Ala 836
Ala
Ala
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Figure 11: Rosetta modeling of amino acids comprising the splice variation of CBS2 in CLH-3a, CLH-3b and 
three mutants. Sequence of the nine amino acids modeled are shown at the bottom of the graph.  The graph 
shows the number of amino acids adopting a helical conformation and the number of Rosetta models that 
predicted that structure. The peak of the histogram corresponds to the median number of amino acids of the 
splice variation that are predicted to adopt a helical conformation. Either the cytoplasmic monomer or just 
CBS2 was held in a fixed conformation and included in predictions to provide a structural context.  A. CLH-3b 
is predicted to be 2 amino acids longer than CLH-3a using the cytoplasmic monomer as a structural context. 
Among the 20,000 models generated, the median number of helical amino acids in CLH-3a and CLH-3b are 
five and seven. B. CLH-3b A836D, CLH-3b L835DA836D and CLH-3b L835KA836K all have a median of 8 
amino acids predicted to be helical, which is comparable or longer than that of WT CLH-3b. 3,000 models 
totally were generated. C. CLH-3b is predicted to be 2 amino acids longer than CLH-3a using CBS2 alone as a 
structural context. Among the 10,000 models totally generated, the median number of helical amino acids in 
CLH-3a and CLH-3b are four and six.  
C
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disrupt the postulated interactions between A836 and F559 are not expected to shorten 
the helix.   
Initially, such calculations were done using only CBS2 as a structural context 
(Figure 11C).  Rosetta predicts the median number of amino acids predicted to adopt a 
helical conformation is 4 for CLH-3a and 5-6 for CLH-3b, which is one amino acid 
shorter than the predictions using the entire cytoplasmic monomer. 
 
 
Predicted effects of mutation of the splice variation on CBS domain stability 
Stability of a protein is measured as the overall potential energy of folding the 
protein.  The effect of a mutation on protein stability is measured by the change in 
potential energy from WT to a mutant, referred to as ∆∆Gmutation.  Table 2 shows these 
values for mutating each of the splice variation amino acids of CLH-3b (shown 
horizontally) to all other amino acids (shown vertically).  A negative value for ∆∆G 
indicates that a mutant is predicted to be more stable than WT, while a positive value 
indicates that a mutant is predicted to be less stable than WT.   
Figure 12A shows a plot of the values in Table 2.  The original amino acid of the 
mutation is shown by a given symbol, while the resulting amino acid of the mutation is 
shown along the horizontal axis.  The first observation is that the most destabilizing 
predicted mutations result in energy changes of 15-60 kcal/mole. These values arise from 
L883Y and mutation of A836 to the bulky amino acids: Phenylalanine (F), Histidine (H), 
Tryptophan, (W), or Tyrosine (Y).  These mutations disrupt and form van der Waals  
 49 
  
 50 
(hydrophobic) interactions, which typically have energies of < 1 kcal/mol, as mentioned 
earlier.  This raises doubt to the accuracy of the values predicted above ~10 kcal/mole.   
The same plot is shown in Figure 12B, expanded to show the lower magnitude 
energy changes.  This graph shows mutation of Y839 usually stabilizes the protein, as 
indicated by a negative ∆∆Gmutation.  Mutation of E838 has little effect on protein stability, 
which concords with its predicted facing of the cytoplasm in the homology model.  
Mutation of amino acids in the splice variation to proline is predicted to have a high 
destabilizing effect, which can be expected since prolines tend to introduce kinks in 
protein structure.  Nonetheless, this analysis does not clearly suggest any amino acids that 
may be more likely to be important for maintaining proper structure.   
Additionally, the effect on stability was calculated for mutating the entire CLH-3b 
splice variations, LRLAEIYLQ, to the sequence of CLH-3a, LRLAIEYLQ. This resulted 
in a ∆∆Gmutation of 10.9, indicating that CLH-3a is predicted to be less stable than CLH-
3b. 
 
 
Discussion 
CBS domain quaternary structure in CLCs 
CBS domain secondary structure is highly conserved and consists of two α-
helices and three β-strands arranged as β1-α1-β2-β3-α2. CBS motifs are typically present 
in proteins as two or, as in CLCs, four copies. Pairs of CBS motifs associate to form a 
dimeric structure known as a Bateman module or domain (e.g., Adams et al., 2004; 
Kemp, 2004; Rudolph et al., 2007). The monomer-monomer interface between two CBS 
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motifs occurs at β-sheets formed by β-strands 2 and 3 (e.g., Hattori et al., 2007; Markovic 
et al., 2007; Meyer et al., 2007; Meyer et al., 2006; Miller et al., 2004; Rudolph et al., 
2007; Zhang et al., 1999). 
CBS dimers also interact to form oligomeric structures. The interface between 
Bateman domains is formed by the α-helices of CBS motifs in a head-to-tail or head-to-
head arrangement (e.g., Hattori et al., 2007; Miller et al., 2004; Rudolph et al., 2007; 
Townley and Shapiro, 2007).  Meyer and Dutzler (Meyer et al., 2006) postulated a head-
to-tail interaction between Bateman domains of the ClC-0 cytoplasmic C-termini (i.e., 
CBS1 of one Bateman domain interacts with CBS2 of the second domain).  However, X-
ray crystallography studies on dimers of ClC-5 and CLC-Ka cytoplasmic C-termini 
revealed a novel interface formed by the CBS2 motifs of each C-terminal monomer 
(Markovic et al., 2007; Meyer et al., 2007).  This “tail-to-tail” arrangement of Bateman 
domains is shown in the CLH-3b homology model in Figure 9.  
 
 
Homology model 
A central question in the CLC field is how the structure of the cytoplasmic region 
regulates channel or transporter function.  Dutzler et al. (Dutzler et al., 2002) have 
suggested that the direct connection between the R-helix and the large cytoplasmic C-
terminus of eukaryotic CLCs could play a critical regulatory role.  The R Helix is 
connected to the cytoplasmic CBS domains via the R helix linker.  The proximity of 
CBS2 to the R Helix linker concurs with the larger effect on channel gating of mutation 
of CBS2, as compared to CBS1 (Estevez et al., 2004).  
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 Despite significant differences in primary sequence, the R-helix linkers of ClC-0, 
CLC-5 and CLC-Ka have similar and well-ordered crystal structures, except for the first 
approximately 10 residues (Markovic and Dutzler, 2007; Meyer et al., 2007; Meyer and 
Dutzler, 2006).  α2 of CBS2 lies close to the R-helix linker in crystal structures of CLC-
0, CLC-5 and CLC-Ka (Markovic and Dutzler, 2007; Meyer et al., 2007; Meyer and 
Dutzler, 2006).  Thus, the R Helix linker may transmit conformational changes from α2 
of CBS2 to the R Helix, and ultimately the channel gate.   
Our homology model suggests that F559 of the R helix linker could interact with 
A836 of α2, and this interaction could be altered due to splice variation.  Figure 10 shows 
that this potential A836-F559 interaction is conserved in crystal structures of CLC-0 and 
CLC-Ka, which are both in the same subfamily of CLCs as the ortholog of CLH-3b, 
CLC-2.  Analysis of sequences reveals that F559 is conserved as a bulky hydrophobic 
amino acid, specifically Phenylalanine, Isoleucine or Valine, in each family member of 
human CLCs.  A836, too, is conserved in members of each CLC channel type (CLC-0 to 
–2, -Ka and -Kb), but not in CLC transporters.   
 
 
Predicting difference in structure between CLH-3a and CLH-3b: length of α-helix 2 
 Modeling methods also suggested that the splice variation is expected to form part 
of α2, and also include uncoiled amino acids C-terminal of α2.  Comparing the predicted 
structure of the splice variants, α2 of CLH-3a is predicted to be 1-2 amino acids (half a 
turn) shorter than α2 of CLH-3b. This uncoiling of α2 in CLH-3a may lead to disruptions 
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of interactions with the R Helix linker, which in turn can affect conformation at the 
channel gate.   
 Similar helix length calculations were done for mutations expected to disrupt the 
postulated A836-F559 interaction, which are CLH-3b A836D, CLH-3b L835DA836D, 
and CLH-3b L835KA836K.  The double mutants were chosen because of the possibility 
of L835 being involved in the putative interaction.  All these mutants show a predicted 
median helix length of 8 amino acids (Figure 11), comparable to the 7 amino acid 
predicted median helix length of CLH-3b.  This suggests that uncoiling of the α2 helix 
via splice variation and disruption of the possible A836-F559 interaction could be 
separate contributors to the difference in gating between CLH-3a and CLH-3b.  One or 
both of these structural elements may be necessary for the difference in channel gating.  
Determining mutations that preserve this A836-F559 interaction, yet are still expected to 
shorten the helix length could provide interesting insights.  Experimental data, which will 
be discussed in chapter III, however, is the ultimate determinant of which structural 
differences between the splice variants regulate channel gating.   
 One should note that, when predicting helix length, we observed a longer helix 
length prediction when the entire cytoplasmic monomer is used as a structural context, as 
opposed to just CBS2 (Figure 11A and 11C).  This observation implies that inclusion of 
the rest of the monomer, i.e. the R helix linker and CBS1, is predicted to impact the helix 
length.  This concurs with the hypothesized interaction between α2 and the R helix 
linker.  Specifically, if there was an interaction, it is possible that the R-Helix linker 
structure can affect the coiling of α2.   
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Predicted effects of mutation of the splice variation on CBS domain stability 
 
 Theoretical calculations were performed predicting the effect of mutations to the 
splice variation on stability of the CBS domain complex.  Mutating A836 to bulky amino 
acids, such as Phenylalanine, Histidine, Tryptophan, or Tyrosine, led to unreasonably 
high predictions of destabilizing energy values.  These values, above 15 kcal/mole, are 
over ten fold greater than typical energy values for hydrophobic interactions.  Such non-
physiologically high predicted energy values can arise from extreme proximity of atoms 
or clashes.  This rise in energy is due to repulsion of atoms, as predicted by the Lennard-
Jones function (Lennard-Jones, 1924).   
Of importance, these energy calculations in Rosetta require the backbone to be in 
a fixed position, which can lead to the clashes upon mutation and result in the unduly 
high predicted energies.  Thus, there are two indirect inferences from these predictions.  
First, the backbone conformation may need to change to avoid clashes when A836 is 
mutated to a bulky hydrophobic amino acid.  Second, A836 is likely forming a tightly 
packed interface with other residues.  The second inference is consistent with the 
predicted A836-F559 interface from analysis of the homology model.  These predictions 
also provide reasons to test the physiological effects of mutating A836.   
The entire CLH-3b splice variations, LRLAIEYLQ, was found to be more stable 
than that of CLH-3a, VCFLISRKK, with ∆∆G between them of 10.9 kcal/mole. The 
implications of such a calculation, however, should be interpreted with caution.  This is 
because such calculations are prone to error when predicting stability changes for 
multiple simultaneous mutations at adjacent positions.  This possible error results from 
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the fact that Rosetta must calculate the new structure at the sites of mutations.  With 
adjacent mutations, Rosetta does not have as complete a structure of the region 
surrounding the point of mutation, and as such, cannot calculate as accurate a new 
structure.   
Several further prediction and experiments are useful for a more accurate 
assessment of the effects of mutations on protein stability.  First, similar energy 
calculations should be done while permitting local backbone movement.  Such a 
procedure would involve homology modeling or de novo building around the site of 
mutation and would be much more computationally expensive.  Second, to reduce 
calculations errors, one should start with a structure where the side chains have been 
minimized by Rosetta as opposed to what we used, Modeller and SCWRL.   
Third, “mutant cycle analysis” (Gleitsman et al., 2009; Schreiber and Fersht, 
1995) using electrophysiology and/or stability calculations can test for the predicted 
interaction.  Specifically, if two residues interface, mutating both residues simultaneously 
should have a non-additive effect on function or stability.  Given that CLH-3b gating 
tends to be discrete, this method may not be as useful by assaying function.  Using 
predictions of stability this method could easily be used to computationally test for the 
predicted A836-F559 interface.  These calculations, however, are somewhat redundant 
with analysis of the model for the purpose of predicting interfaces.  Nonetheless, such 
calculations on A836 and F559 could aid in choosing residues to mutate to in order to 
disrupt or recreate the predicted interface.  Ultimately, the meaning of all these 
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predictions of effects of mutations on stability can be put into perspective with 
electrophysiological studies of mutants. 
 
Closing Remarks 
In conclusion, our modeling allows us hypothesize that the differences in 
channel gating between CLH-3a and CLH-3b are mediated via possible interactions 
of the splice variation with the R-Helix linker.  In particular, this interaction is 
hypothesized to occur between A836 of the splice variation and F559 of the R Helix 
linker.  Our modeling also suggests that the CBS domains of CLH-3a may be less stable 
than those of CLH-3b. These possibilities will be explored via electrophysiology and 
mutagenesis, described in chapter III. 
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CHAPTER III 
 
 
UNIQUE GATING PROPERTIES OF C. ELEGANS CLC ANION  CHANNEL 
SPLICE VARIANTS ARE DETERMINED BY ALTERED CBS DOMAIN 
CONFORMATION AND THE R-HELIX LINKER 
 
 
Summary 
All eukaryotic and some prokaryotic CLC anion channels and transporters have 
extensive cytoplasmic C-termini containing two cystathionine-β-synthase (CBS) 
domains. CBS domain secondary structure is highly conserved and consists of two α-
helices and three β-strands arranged as β1-α1-β2-β3-α2. Mutations in CLC CBS domains 
give rise to muscle and bone disease and alter CLC gating. However, the precise 
functional roles of CBS domains and the structural bases by which they regulate CLC 
function are poorly understood. CLH-3a and CLH-3b are C. elegans CLC anion channel 
splice variants with strikingly different biophysical properties. Splice variation occurs at 
cytoplasmic N- and C-termini and includes several amino acids that form α2 of the 
second CBS domain (CBS2). We demonstrate that interchanging α2 between CLH-3a 
and CLH-3b interchanges their gating properties. The R-helix of CLC proteins forms part 
of the ion conducting pore and selectivity filter and is connected to the cytoplasmic C-
terminus via a short stretch of cytoplasmic amino acids termed the R-helix linker. C-
terminus conformation changes could cause R-helix structural rearrangements via this 
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linker. Crystal structures of cytoplasmic domains of three CLC proteins suggest that α2 
of CBS2 interacts with the R-helix linker. We found that mutating predicted α2 and R-
helix linker interacting amino acids in CLH-3b was sufficient to give rise to CLH-3a-like 
gating. We postulate that the R-helix linker via its interaction with CBS2 provides a 
pathway by which cytoplasmic C-terminus conformational changes induce 
conformational changes in membrane domains that in turn modulate CLC function.   
 
 
Introduction 
The structural bases by which the cytoplasmic C-terminus controls CLC gating 
and activity are poorly understood.  We have exploited the distinct functional differences 
of the splice variants CLH-3a and CLH-3b to address this question.  The discrete 
sequence differences due to splice variation and the clear functional differences make the 
channels an excellent model system for structure-function studies (see chapter I). 
Moreover, previous studies show mutations in CLH-3a or CLH-3b did not yield novel or 
intermediate gating (He et al., 2006; Denton et al., 2006).  To summarize gating 
differences, CLH-3a has a more negative activation voltage, a slower opening kinetics, is 
sensitive to depolarized holding potentials, and has increased sensitivity to pH and Cl- 
(Figure 3).  Work in our lab over the past several years has set a foundation for detailed 
structure function analysis of CLCs, using the model system of CLH-3a and CLH-3b.  
The C. elegans gene knockout project generated a worm strain, ok768, containing 
a clh-3 deletion mutation.  This mutation removes the 101 amino acid splice insert unique 
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to CLH-3b and an additional 64 upstream amino acids shared by both channels (Figure 2 
and 13).  Eleven of these amino acids are located at the end of CBS1 (Figure 13).  The  
 
 
 
 
mutant channel exhibits voltage-dependent gating and pH and Cl- sensitivity that 
resemble CLH-3a (Denton et al., 2006).  This mutant also virtually abolishes channel 
sensitivity to cell swelling.  Thus, these sets of deleted amino acids induce CLH-3a like 
gating in CLH-3b and regulate volume sensitivity of CLH-3b.  
CLH-3a    (1) MPSRTPLSKIEWQSLLPLPPEKSEKDATIENNEELEKIRMPAGKEYDLQPGSHLGVYKTVRGLPIDEDSKSMGIGTKIL 
CLH-3b    (1) -----------------------------------------------------------------------MGIGTKIL 
 
CLH-3a   (80) SKIEKNKTSDGLTIPLTPTTQKQSSSWCSFESIKTFFRT//…………………………………………………………………………………………………… 
CLH-3b    (9) SKIEKNKTSDGLTIPLTPTTQKQSSSWCSFESIKTFFRT//…………………………………………………………………………………………………… 
 
CLH-3a  (607) KNLPYLPDIPHTTSLYHQMLIEQFMISPLVYIAKDSTVGDIKRALETKTRIRAFPLVENMESLALVGSVSRSQLQRYVD 
CLH-3b  (536) KNLPYLPDIPHTTSLYHQMLIEQFMISPLVYIAKDSTVGDIKRALETKTRIRAFPLVENMESLALVGSVSRSQLQRYVD 
 
CLH-3a  (686) SQIGTKARFAEATRRIKQRLEDEESERKRREESKSDDTEDSLETTGAGERRAS-------------------------- 
CLH-3b  (615) SQIGTKARFAEATRRIKQRLEDEESERKRREESKSDDTEDSLETTGAGERRASRFLIVPVAKNGPQVAKNETLTGLSEE 
 
CLH-3a  (739) ---------------------------------------------------------------------------RYEW 
CLH-3b  (694) NARKILTVEEKQALFDAASLATPKREMSGKTINPVHIESHHTIGDIFRSITHLSFGRQNFPKKNNHNEFDLFGEERTEW 
 
CLH-3a  (743) EDMMLNQKLDLSQLDIDSTPFQLSEYTSLFKAHSLFSLLGLNRAYVTKKGQLIGVVALKEVCFLISRKK---------- 
CLH-3b  (773) EDMMLNQKLDLSQLDIDSTPFQLSEYTSLFKAHSLFSLLGLNRAYVTKKGQLIGVVALKELRLAIEYLQSGKVPTPGMS 
 
CLH-3a  (822) ------------------------------------------------------------------------------- 
CLH-3b  (852) IFNEPPTEQSIYEKSARLESGRATGDAQNAAFVTDNGEDDAQNDYIQPPLEVVRRGALTPNRMSELTRLENVRTTPESP 
 
CLH-3a  (901) ----------------------------------------------------------------------- 
CLH-3b  (931) HFEVSSPSTSSSCVSIDFSPLDAANSENGSVGGLVLNVPSLPTRARSANELTRQNTHVQINLPDDVHDEKF 
Figure 13.  Sequence of predicted intracellular N- and C-termini of CLH-3a and CLH-
3b.  Intramembrane domains have identical sequence and are omitted for clarity.  
Double vertical lines indicate start of intramembrane sequence, which ends at residues 
613 for CLH-3a and 542 for CLH-3b.  Splice variations in CLH-3a and CLH-3b are 
highlighted in yellow and green, respectively.  Location of CBS domains were 
predicted using the domain recognition programs PFAM (Finn et al., 2006), 
InterProScan (Zdobnov et al., 2001) and MyHits (Pagni et al., 2004) and are outlined 
with boxes.   
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Deletion of the 101 amino acids (amino acids 668-768), alone, did not affect 
sensitivity to depolarized voltages, pH or Cl-.  Deletion of the 101 amino acids, however, 
did shift the activation voltage to ~-65mV and slowed current activation kinetics (He et 
al., 2006), as seen in CLH-3a and in CLH-3b phosphorylated by GCK-3 (Denton et al., 
2005).  Recent studies have identified GCK-3 phosphorylation sites within these 101 
amino acids (Falin et al., 2009).   
Deletion of the 11 CBS1 amino acids alone, CLH-3b∆604-614, in the mutant 
worm strain induced CLH-3a like gating.  Specifically, gating refers to CLH-3a like 
activation voltage, kinetics, and sensitivity to pH, Cl-, and depolarizing holding 
potentials.  Deletion of the remaining 53 of the 64 amino acids largely retained CLH-3b 
like gating (He et al., 2006). Thus, it was hypothesized that CBS domain configuration 
regulated difference in gating between CLH-3a and CLH-3b.  Nonetheless, these 11 
amino acids in CBS1 are identical in the channels, so some other sequence difference 
must also be contributing to the difference in gating.   
Major differences in CLH-3a and CLH-3b sequence (Figure 2 and 13) are an N 
terminal addition in CLH-3a, a 160 C-Terminal extension in CLH-3b, and the insertion of 
101 aforementioned amino acids.  The last nine amino acids of CLH-3a, including part of 
CBS2, are also alternatively spliced compared to their CLH-3b homologs. Neither 
deleting the 71 amino acids in CLH-3a, nor adding them onto the N-terminus of CLH-3b, 
affected gating of either channel.  As mentioned, the 101 amino acids do not regulate 
gating differences between CLH-3a and CLH-3b.  Deletion of the C-terminal extension, 
plus the preceding 9 spliced amino acids (CLH-3b ∆833-1001) did induce CLH-3a like 
 61 
gating in CLH-3b.  Thus, gating difference between CLH-3a in CLH-3b were known to 
be regulated through CBS1, the 9 amino acids splice variation that includes the C-
terminus of CBS2, and/or the 160 amino acid extension.   
The fact that deleting non-spliced amino acids of CBS1 affected gating led us to 
hypothesize that proper overall CBS domain configuration is essential for normal channel 
gating. I proceeded to test this hypothesis by making mutations in CBS2 of CLH-3b, as 
well as both CBS domains of CLH-3a.  This hypothesis concords with the known 
interaction of CBS1 with CBS2, shown in CLC cytoplasmic region crystal structures 
(Markovic and Dutzler, 2007; Meyer et al., 2007; Meyer and Dutzler, 2006), as well the 
importance of CBS domains in regulating channel gating (Bennetts et al., 2007; Yusef et 
al., 2006; Lin et al., 2006; Wu et al., 2006; Estevez et al., 2004; Denton et al., 2006; He et 
al., 2006; Bennetts et al., 2005). 
In this study, we make use of our homology model (Figure 9) and mutagenesis to 
further characterize the role of C-terminus splice variation in regulating CLH-3b gating.  
This nine amino acid splice variation of CLH-3a and CLH-3b includes the second α-helix 
(α2) of the second CBS domain (CBS2) (Figure 11A).  Our results show that 
interchanging α2 between the two channels interchanges their gating properties.   
Homology modeling (chapter II) suggests that α2 may interact with a short stretch 
of amino acids, termed the R-helix linker, which connects the membrane helix R to the 
intracellular C-terminus (Figures 9 and 10A).  Dutzler and colleagues (Dutzler et al., 
2002) have first suggested that the R-helix could provide a pathway by which 
conformational changes in intracellular domains regulate channel/transporter function 
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(Figure 7).  Consistent with this model, we found that mutating predicted interacting 
amino acids in α2 and the R-helix linker of CLH-3b was sufficient to give rise to CLH-
3a-like gating.  Our studies provide novel insights into the role of CBS domains, the R-
helix linker and cytoplasmic C-terminus conformational changes in regulating CLC 
gating properties.   
 
 
Material And Methods 
Transfection and Whole Cell Patch clamp Recording 
HEK293 (human embryonic kidney) cells were cultured in 35 mm diameter tissue 
culture plates in “complete MEM media”, which consisted of Eagle's minimal essential 
medium (MEM; Gibco, Gaithersburg, MD) containing 10% fetal bovine serum (Hyclone 
Laboratories, Inc., Logan, UT), non-essential amino acids, sodium pyruvate, 50 U/ml 
penicillin and 50 µg/ml streptomycin.  Cells were plated at 200K-500K cells/dish.  One 
to three days later, after reaching 50-70% confluency, cells were transfected using 
FuGENE 6 (Roche Diagnostics Corporation, Indianapolis, IN) with 1 µg GFP and 1-8 µg 
of channel cDNAs ligated into pcDNA3.1.  Typically, 5µg channel DNA was used, with 
the following  exceptions: 3b∆842-1001 (8 µg), CLH-3b834-1001 (3µg) cotransfected 
with CLH-3b ∆834-1001 (4ug), CLH-3a + YLQ (8µg), CLH-3b∆661-1001 cotransfected 
with CLH-3b 661-1001 (3 µg each), CLH-3b H552D (1µg), and CLH-3b A836K (1-2 
µg). A ratio of 3 µL FuGENE to 1µg DNA was used for transfection.   
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Mutagenesis 
Channel point mutants were generated using a QuikChange Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA). Stratagene's QuikChange II XL site-directed 
mutagenesis kit was necessary for mutations to the R Helix linker of CLH-3b (amino 
acids 544 to 562).  Carbamicine plates were made at 100 mg/mL.  All point mutation 
primers were designed using Stratagene’s online automatic primer design program.  
Deletion mutagenesis was done using PCR fusion based strategies, except for 
CLH-3a∆792-808.  Specifically, fragments (designated AB and CD) of the channel 
encoding DNA on either end of the deletion were amplified.  For each fragment, primers 
on the side of the deletion contained short stretches of DNA that pair with the other side 
of the deletion.  The two PCR fragment products (AB and CD) were used as a template 
for a third PCR, containing primers spanning the whole insert (designated AD).  Then, 
the insert was ligated into the PC DNA 3.1+ vector.  Positive ligations were identified 
using DNA sequencing or restriction enzyme based PCR screens.   
CLH-3a∆792-808 was made using the Stratagene’s QuickChange Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA).  There are only three amino acids, RKK, 
remaining in CLH-3a∆792-808 after the point of deletion.  Thus, the mutant was made by 
substituting the first four amino acids of the deletion with RKK, followed by a stop 
codon.  The following table shows primers used for the three deletions mutants. 
Split channels were made by introducing stop codons with the Stratagene kit for 
the first half and by performing PCR over the second half.  Restriction enzymes sites 
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were incorporated into the PCR primers for the second half, and these were used to ligate 
into the vector DNA.  Positive ligations were identified using a PCR screen. 
 
 
Mutant Sequence 
CLH-3b∆822-838 
AB 
F:GTTAAGCTTGGTACCGCATGGGTATTGGTACAAAAATAT
TATC 
R:GCACTTTTCCAGATTGTAAATATTTTTTCGTCACGTATGC
ACG 
CLH-3b∆822-838 
CD 
F:TATTTACAATCTGGAAAAGTGC 
R:CTAGACTCGAGCGGCCGCTCAGAATTTTTCGTCATGAAC
G 
CLH-3b∆822-838 
AD 
F:GCTTGGTACCGCATGGGTATTGGTACAAAAATATTATC 
R:CGTTCATGACGAAAAATTCTGAGCGGCCGCTCG 
CLH-3a∆792-808  F:TCTCACTTCTTGGTCTAAATCGTGCATACGTGACGAAAA
AACGGAAAAAGTAGGGCGTTGTCGCATTAAAAGAG 
CLH-3a∆675-685 
AB 
F:GGCTTATCGAAATTAATACGACTCACTATAGGGAGACCC
AA 
R: 
CGGGCTTTTGTTCCAATTTGAGACGAACCGACAAGAGCTA 
CLH-3a∆675-685 
CD 
F:TCTCAAATTGGAACAAAAGC 
R:GGGTTAGGGATAGGCTTACC 
CLH-3a∆675-685 
AD 
F:CGAAATTAATACGACTCACTATAGG 
R:ATGGCTTACCTTCGAACCG 
Table 3: Primers used for deletion mutants.  Forward (F) and reverse (R) listed, 5’ to 3’. 
 
 
All mutants were confirmed by DNA sequencing.  
All channel plasmids were grown via transformation in Stable 2 E. Coli.  5-10 pg 
DNA were transformed into 100 µL stable 2 and heat shocked at 42 deg C for 25 
seconds.  Subsequently, they were placed on ice for ~2 minutes, and then 900 uL S.O.C. 
medium was added.  This 1mL mixture was incubated for 90 minutes at 30 deg C, 
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shaking at 225 RPM.  After that, 900 uL of the mixture was added to 40-50 mL Terrific 
Broth with 100mg/mL Carbamicine, and grown for 26-40 hours at 30 degrees.  Qiagen 
MIDI preps were used to isolate plasmid DNA.   
GFP was grown via transformation into DH5α E. coli.  0.5uL DNA was 
transformed into 50 uL DH5a and heat shocked at 42 deg C for 45 seconds.  
Subsequently, the transformation was placed on ice for ~2 minutes, and 900 uL S.OC. 
medium was added.  This mixture was plated on 50mg Carbamicine/mL LB plates and 
grown overnight for ~ 16 hrs at 37 deg C.  The next day, one colony was picked and 
grown in 40-50  mL LB with NaCl.  DNA was purified using a Qiagen MIDI prep.   
 
 
Voltage clamp electrophysiology preparation 
All experiments were performed on at least two independently transfected groups 
of cells.  Following transfection, cells were incubated at 37ºC for 24-30 hours.  Cover 
slips were coated with poly-L-lysine for at least 25 minutes, and then the poly-L-lysine 
was rinsed off three times with sterilized water.  Approximately 2 h prior to patch clamp 
experiments, cells were detached from growth plates by exposure to 0.25% trypsin 
containing 1 mM EDTA (Gibco) for 45 sec.  Detached cells were suspended in complete 
MEM media, centrifuged, resuspended in fresh media, and then plated onto the poly-L-
lysine coated cover slips.  Approximately 1 hour after plating, 2 mL complete MEM 
media was pippetted onto the cells, and the cells incubated with media for at least one 
hour.  Plated cover slips were placed in a bath chamber mounted onto the stage of an 
 66 
inverted microscope.  Cells were visualized by fluorescence and differential interference 
contrast microscopy.   
Transfected cells were identified by GFP fluorescence and patch clamped using a 
bath solution that contained 90 mM NMDG-Cl, 5 mM MgSO4, 1 mM CaCl2, 12 mM 
Hepes free acid, 8 mM Tris, 5 mM glucose, 80 mM sucrose and 2 mM glutamine and was 
titrated to pH 7.4 with Hepes free acid and Tris (297-303 mOsm), and a pipette solution 
containing 116 mM NMDG-Cl, 2 mM MgSO4, 20 mM Hepes titrated to pH 7.0 with 
CsOH, 6 mM CsOH, 1 mM EGTA titrated to pH 8.3-8.5 with CsOH, 2 mM ATP, 0.5 
mM GTP, and 10 mM sucrose (pH 7.2, 274-280 mOsm).  Low pH bath solution 
contained 90 mM NMDG-Cl, 5 mM MgSO4, 1 mM CaCl2, 5 mM glucose, 80 mM 
sucrose and 2 mM glutamine and was titrated to pH 5.9 using Hepes free acid, (297-303 
mOsm).  Low Cl bath solution contained 10 mM NMDG-Cl, 80mM NMDG-Gluconate, 
5 mM MgSO4, 1 mM CaCl2, 5 mM glucose, 80 mM sucrose and 2 mM glutamine and 
was titrated to pH 7.4 using Hepes free acid (297-303 mOsm).   
Patch electrodes with resistances of 3-7 MΩ were pulled from 1.5 mm outer 
diameter silanized borosilicate microhematocrit tubes. Whole cell currents were 
measured with an Axopatch 200B (Axon Instruments, Foster City, CA) patch clamp 
amplifier.  Electrical connections to the patch clamp amplifier were made using Ag/AgCl 
wires and 3 M KCl/agar bridges.  Data acquisition and analysis were performed using 
pClamp 10 software (Axon Instruments).   
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Voltage Clamp Protocols and Data Analysis 
Whole cell currents were evoked by stepping membrane voltage for 1 sec between 
-120 mV and +100 mV in 20 mV increments from a holding potential of 0 mV.  Test 
pulses were followed by a 1 sec interval at 0 mV.  Current-to-voltage relationships were 
constructed from mean current values recorded over the last 25 msec of each test pulse.  
For pre-depolarization studies, cells were held at holding voltages of -20 mV to 60 mV 
for 3 sec and then stepped to -120 mV for 3 sec to activate channels.  Peak 
hyperpolarization induced current amplitude was measured over a 100 msec interval.  
Pseudo-steady-state current was measured over the last 20 msec of the –120 mV test 
pulse.   
Each trace was taken for at least two trials.  If the current magnitude was not 
consistent between these trials, the data from the traces were discarded.  Cell size was 
monitored with a DIC camera, and data recording was stopped on a given cell if it 
displayed swelling or shrinkage.  Only single isolated cells were patched. 
Channel activation voltages were estimated from current-to-voltage relationships.  
A line was drawn by linear regression analysis of currents measured between 20 mV and 
100 mV.  A second line was drawn by linear regression analysis of currents measured 
between the first voltage at which inward current was detected and a second voltage 20 
mV more negative.  The intercept of these two lines is defined as the activation voltage.   
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Statistical Analysis 
Data are presented as means ± S.E.  Statistical significance was determined using 
Student’s two-tailed t test for unpaired means.  When comparing three or more groups, 
statistical significance was determined by one-way analysis of variance with a Tukey 
post-hoc test.  P values of <0.05 were taken to indicate statistical significance.   
 
 
Results 
Large deletion mutations in CLH-3b CBS domains give rise to CLH-3a-like gating  
Figure 13 shows the sequence of the predicted intracellular domains of CLH-3a 
and CLH-3b.  The membrane-associated domains of the two channels are identical 
(Denton et al., 2004) and have been omitted from the figure for clarity.  Splice variation 
occurs in cytoplasmic regions of the channels and includes a 71 amino acid extension of 
the CLH-3a N-terminus, a 101 amino acid insert located between CBS1 and CBS2 in 
CLH-3b and a 160 amino acid extension of the CLH-3b C-terminus.  In addition, eight of 
the last nine C-terminal amino acids of CLH-3a are distinct from those in the same region 
of CLH-3b.  Six of these nine amino acids are predicted to be located at the end of CBS2. 
Studies using C. elegans deletion mutants (He et al., 2006) have demonstrated 
that disruption of CLH-3b CBS1 domain structure gives rise to channels with CLH-3a 
functional properties.  In addition, deletion of the last 169 amino acids of CLH-3b, which 
includes part of CBS2 (Figure 13), yields channels that have gating properties identical to 
those of CLH-3a.  To determine whether disruption of CBS2 structure per se was 
responsible for this effect, we deleted the last seventeen amino acids (residues 822-838) 
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of CBS2 in CLH-3b.  Figure 14 shows the characteristics of wild type CLH-3a and CLH-
3b and the mutant channel CLH-3b∆822-838.  Both CLH-3a and CLH-3b show strong 
inward rectification and activation at hyperpolarized voltages (Figure 14A).  However, 
CLH-3a activation requires much stronger hyperpolarization.  Mean activation voltages 
were -54 mV for CLH-3a and -27 mV for CLH-3b (Figure 14B).  Deletion of the last 
seventeen amino acids of CBS2 in CLH-3b induced a hyperpolarizing shift in activation 
voltage (Figures 14A-B).  The mean activation voltage of CLH-3b∆822-838 was ~-52 
mV and was not significantly (P>0.6) different from that of CLH-3a.   
CLC channels are activated by extracellular acidification (Jentsch et al., 2002).  
Reduction of bath pH to 5.9 activates CLH-3a and CLH-3b ~3.2- and ~1.6-fold, 
respectively.  Deletion of amino acids 822-838 significantly (P<0.001) increased the pH 
sensitivity of CLH-3b resulting in a ~4.4-fold activation by reducing bath pH to 5.9 
(Figure 14C).   
CLH-3a shows unique sensitivity to depolarized holding voltages termed pre-
depolarization induced potentiation (He et al., 2006; Denton et al., 2006; Denton et al., 
2004).  As shown in Figures 14D-E, increasing the degree of holding potential 
depolarization increases the extent of or “potentiates” hyperpolarization induced current 
activation.  Currents potentiated by pre-depolarization also undergo slow, partial 
inactivation (Figures 14D and F).  Wild type CLH-3b is insensitive to depolarized 
holding voltages (Figures 14 D-F).  However, the deletion mutation in CBS2 induced 
sensitivity to pre-depolarization that resembled that of CLH-3a (Figures 14D-F).  Taken 
together, data in Figure 14 and our previous studies (Denton et al., 2006; He et al., 2006) 
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demonstrate that disruption of either CBS1 or CBS2 structure in CLH-3b gives rise to 
channels with CLH-3a-like biophysical properties. 
In contrast to CLH-3b, deletion of the last 11 amino acids of CBS1 or the last 17 
amino acids of CBS2 in CLH-3a had no effect on voltage and pH sensitivity (Figures 
15A-B) or the response to depolarized holding potentials (Figure 15C-D).  These data 
demonstrate that the unique gating properties of CLH-3a are insensitive to disruption of 
CBS domain conformation.   
 
 
The C-terminal extension does not regulate gating differences of splice variants  
Our previous studies showed that gating differences between CLH-3a and CLH-
3b are regulated by CBS domains or the C-terminal 160 amino acid extension of CLH-
3b.  In this study, a split channel was made coexpressing CLH-3b∆833-1001 (CLH-3b 
truncated at the start of the nine amino acid splice variation) and the remaining C-
terminus, CLH-3b 833-1001.  Preliminary data on this coexpression had gating 
resembling CLH-3a, no different from the published data of CLH-3b∆833-1001(He et al., 
2006).  Because there was no effect of coexpressing the plasmids, as compared to the 
plasmid for the N-terminal region alone, this experiment was inconclusive and not 
pursued further. 
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Figure 14.  CLH-3b CBS domain deletion mutations give rise to CLH-3a-like gating.  
Current-to-voltage relationships, activation voltages and activation by bath 
acidification are shown in A, B and C, respectively.  Effects of depolarized holding 
potentials are shown in D, E and F.  D. Representative current traces showing 
hyperpolarization induced current activation in cells held at depolarized holding
potentials.  Cells were held at voltages of -20 to 60 mV for 3 sec before currents were 
activated by stepping to -120 mV.  E. Current activation by depolarized holding 
potentials.  Peak current amplitudes are normalized to that measured following a 
holding potential of –20 mV (I
-20 mV holding potential).  F. Effect of holding 
potential on current inactivation.  Mean pseudo-steady-state current (Isteady state) was 
measured over the last 20 msec of the –120 mV test pulse and normalized to peak 
current (Ipeak) amplitude.  Values in A, B, C, E and F are means ± S.E. (n=5-12).  
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Figure 15.  CLH-3a gating is unaffected by large deletion mutations in CBS1 or 
CBS2.  A. Activation voltage.  B. Activation by bath acidification.  C. Current 
activation by depolarized holding potentials.  D. Effect of holding potential on current 
inactivation.  Data in C and D were acquired as described in Figure 14 legend.  Values 
are means ± S.E. (n=4-12).  
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Next CLH-3b∆842-1001, which had this 160 amino acid extension deleted, was 
created, and gating was assessed.  CLH-3b∆842-1001’s sensitivity to depolarizing 
holding voltages clearly mimicked that of CLH-3b (data not shown).  External pH of 5.9 
magnified current by a factor of 2.42 + 0.21 and external [Cl-] of 12 mM decreased 
current to 0.86 + 0.026  of the original value.  These data were significantly less than the 
pH and Cl- sensitivity of CLH-3a (P<0.05), and CLH-3b∆842-1001’s activation voltage 
(-40.9 + 0.27) was also significantly less negative than that of CLH-3a (P<0.01).  This 
demonstrates that the 160 amino acid C-terminal extension, which follows 3 amino acids 
C-terminal of the predicted CBS2 in CLH-3b, does not mediate gating differences 
between CLH-3a and CLH-3b. 
 
 
Splice variation of CBS2 determines CLH-3a and CLH-3b gating characteristics  
The primary sequence of CBS domains in diverse proteins is variable, but the 
motif has a highly conserved secondary structure consisting of an N-terminal β-strand 
(β1) followed by an α-helix (α1), two β-strands (β2 and β3) and an α-helix (α2) 
(Bateman, 1997; Ignoul and Eggermont, 2005).  As shown recently by Dutzler and 
coworkers (Markovic and Dutzler, 2007; Meyer et al., 2007), CBS1 and CBS2 domains 
play an important role in determining the overall homodimeric structure of the 
cytoplasmic regions of CLC proteins.  Large deletions in either CBS1 or CBS2 are 
expected to dramatically disrupt C-terminus conformation and function.  Our deletion 
mutation studies (Figures 14-15) as well as previous work (Denton et al., 2006; He et al., 
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2006) demonstrate that overall CBS domain architecture plays a critical role in 
determining CLH-3b but not CLH-3a functional properties.   
As shown in Figure 13, CBS2 domains of CLH-3a and CLH-3b predicted using 
the domain recognition programs PFAM (Finn et al., 2006), InterProScan (Zdobnov and 
Apweiler, 2001) and MyHits (Pagni et al., 2004) are alternatively spliced at the last six 
amino acids.  This region forms part of α2.  The sequences of the six splice variant amino 
acids in CLH-3a and CLH-3b are VCFLIS and LRLAIE, respectively.   
We postulated that splice variation of α2 may be a critical determinant of channel 
biophysical properties.  To test this hypothesis, we interchanged the six alternatively 
spliced amino acids between the channels.  CLH-3b+VCFLIS exhibited a hyperpolarized 
activation voltage (Figure 16A), increased pH sensitivity (Figure 16B) and sensitivity to 
depolarized holding potentials (Figures 16C-D).  Replacement of the last six amino acids 
in CBS2 of CLH-3a with the analogous amino acids in CLH-3b (CLH-3a+LRLAIE) had 
little effect on activation voltage or pH sensitivity (data not shown).   
The response of CLH-3a+LRLAIE to pre-depolarization was variable between 
cells.  Of the 15 cells that were patch clamped from two separate transfections, we found 
that two cells showed a strong response to pre-depolarization resembling that of wild type 
CLH-3a, seven cells showed no response and six cells exhibited a weak response (data 
not shown).  This variability suggested to us that additional spliced amino acids may 
contribute to channel gating properties.  Additionally, our modeling results (Figure 11) 
showed that the first 5 spliced amino acids in CLH-3a are predicted to be helical, while in 
CLH-3b the a2 helix is predict to extend to include seven spliced amino acids.   
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Figure 16.  Interchanging alternatively spliced amino acids in CBS2 interchanges 
channel functional properties.  A. Activation voltage.  B. Activation by bath 
acidification.  C. Current activation by depolarized holding potentials.  D. Effect of 
holding potential on current inactivation.  Data in C and D were acquired as described 
in Figure 14 legend.  Values are means ± S.E. (n=5-11).  
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Given the possible differences in α2 length and the variable response of CLH-
3a+LRLAIE to depolarizing voltages, we interchanged the last nine amino acids of CLH-
3a with the analogous amino acids of CLH-3b.  The activation voltage of CLH-
3a+LRLAIEYLQ remained hyperpolarized and pH sensitivity was similar to that of wild 
type CLH-3a (Figures 16A-B).  However, in contrast to CLH-3a+LRLAIE, none of the 
currents recorded from CLH-3a+LRLAIEYLQ expressing cells (10 cells in six separate 
transfections) showed sensitivity to depolarized holding potentials (Figures 16 C-D).   
To determine whether the last three amino acids of CLH-3a (i.e., RKK) 
independently regulate channel properties, we exchanged them with the analogous amino 
acids of CLH-3b (i.e., YLQ).  Replacing RKK with YLQ (i.e., CLH-3a+YLQ) had no 
significant effect on pH sensitivity or activation voltage (P>0.7) or sensitivity to 
depolarized voltages (data not shown).  Similarly, CLH-3b+RKK showed pH sensitivity 
similar to that of wild type CLH-3b and was insensitive to pre-depolarization (data not 
shown).  However, the activation voltage for CLH-3b+RKK was similar to that of CLH-
3a (see Figure 14B) and significantly (P<0.0001) hyperpolarized compared to CLH-3b 
with a mean ± S.E. value of -51 ± 1 mV (n=13).   
 
 
The R-helix linker plays a critical role in determining CLH-3a and CLH-3b gating 
properties  
Data in Figure 16 demonstrate that splice variation of α2 of CBS2 plays a major 
role in determining the gating characteristics of CLH-3a and CLH-3b.  Differences in the 
primary and secondary structure of α2 could alter local interactions within the channel 
 78 
that give rise to unique gating properties.  Our homology models of the cytoplasmic C-
termini of CLH-3a and CLH-3b (Figure 9) have provided insights into such interactions.   
The 20 amino acid R-helix linker connects the C-terminus of the R-helix of 
CLH-3a and CLH-3b to the N-terminus of CBS1 (Figure 17A).  The R-helix forms part 
of the channel pore and selectivity filter.  Cytoplasmic domains may modulate the 
conformation of the R-helix and thus channel properties (Dutzler et al., 2002).   
Crystal structures of ClC-0, CLC-Ka and ClC-5 cytoplasmic C-termini 
(Markovic et al., 2007; Meyer et al., 2007; Meyer et al., 2006) indicate that part of the 
cytoplasmic R-helix linker lies close to and may therefore interact with α2 of CBS2 
(Figure 9).  This suggested that the linker could play an important role in mediating the 
differences in CLH-3a and CLH-3b gating induced by α2 splice variation. 
As discussed in Chapter II, the homology models indicated that F559 in the R-
helix linker of CLH-3b lies very close to A836 in α2 of CBS2 (Figure 17B).  The 
orientation of the homologous phenylalanine in CLH-3a, F630, could be altered due to 
the presence of a bulkier leucine residue, L806, at the corresponding position in α2.  To 
test whether F559 plays a role in regulating channel properties, we mutated it to aspartate 
(F559D).  As shown in Figures 7A-D, this mutation gave rise to CLH-3a-like voltage and 
pH sensitivity and sensitivity to depolarized holding potentials.  In contrast, mutation of 
F630 to aspartate in CLH-3a had no effect on channel properties (data not shown). 
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Figure 17. Depictions of mutated amino acids. A. Sequence of the R-helix and R-
helix linker in CLH-3b.  Asterisks denote mutated amino acids in the R-helix linker.  
B. Ribbon diagrams showing the relationship of mutated amino acids in α2 of CBS2 
to F559 in the R-helix linker and α1.  
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To determine whether the channel gating was uniquely sensitive to mutation of 
F559, we also performed charge addition or charge swapping mutations to the 
neighboring amino acids H552, M554, E557, or M560 (see Figure 17A).  None of these 
amino acids were predicted to have strong interactions with α2.  Consistent with this 
prediction, mutation of M554 or E557 to lysine or H552 or M560 to aspartate had no 
effect on CLH-3b gating (Figure 18A-D).   
We then mutated A836 to aspartate, phenylalanine, and lysine.  The A836D 
mutant gave rise to a small hyperpolarizing shift in activation voltage and potentiation 
behavior that was considerably less than that observed with wild type CLH-3a (data not 
shown).  The A836F mutant gave rise to pH sensitivity (preliminary data, n=3), 
activation voltage, and potentiation that resembled those of CLH-3b (data not shown).  
We therefore mutated A836 to a large and positively charged amino acid, lysine.  The 
A836K mutant exhibited voltage and pH sensitivity nearly identical to those of CLH-3a 
(Figure 19A-D).   
To summarize, F559D and A836K both induce CLH-3a like gating and are 
predicted to interface.  Thus, we constructed the double mutant CLH-3b F559D / A836K.  
If F559 and A836 interact, this mutant may reconstitute the interaction with a salt bridge.  
The double mutant CLH-3b F559D / A836K had pH sensitivity, activation voltage, and 
sensitivity to depolarized holding potentials closely resembling that of CLH-3a (data not 
shown), which is similar to gating of CLH-3b F559D or CLH-3b A836K.  Because of the 
absence of an effect, no conclusions could be drawn. 
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Figure 18.  A single point mutation in the R-helix linker gives rise to CLH-3a-like 
gating.  (A) Activation voltage.  (B) Activation by bath acidification.  (C) Current 
activation by depolarized holding potentials.  (D) Effect of holding potential on 
current inactivation.  Data in (C) and (D) were acquired as described in Figure 14 
legend.  Values are means ± S.E. (n=5-12).  Wild type CLH-3a and CLH-3b gating 
are shown in Figure 14. 
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We also mutated amino acids immediately adjacent to A836.  Mutation of L835 to 
lysine (L835K) had no effect on the voltage or pH sensitivity of CLH-3b while mutating 
I837 to lysine (I837K) gave rise to CLH-3a-like behavior (Figure 19A-D).  Both amino 
acids are predicted to face away from the R-helix linker (Figure 17B).  Crystal structures 
of various tandem CBS domain containing proteins indicate that that α1 and α2 lie close 
together and may physically interact (e.g. Meyer et al., 2006; (Miller et al., 2004; 
Markovic and Dutzler, 2007; Meyer et al., 2007; Zhang et al., 1999).  We examined the 
CLH-3b homology model to assess the relationship of α2 amino acids to α1 in CBS2.  As 
shown in Figure 17B, L835 faces away from α1 while I837 faces towards it and could 
interact with amino acids on this helix.  This suggests that the I837K mutation may 
disrupt putative α1-α2 interactions.  To test this possibility, we mutated L833, which also 
lies close to α1 (Figure 17B), to glutamate (L833E).  The L833E mutant exhibited CLH-
3a-like behavior (Figures 19A-D).  Data shown in Figures 14-16 and 18-19, and our 
previous findings (Denton et al., 2006; He et al., 2006) indicate that mutations that 
disrupt CBS domain structure and/or putative interactions of CBS2 with the R-helix 
linker give rise to gating characteristics resembling those of CLH-3a.  
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Figure 19.  Mutation of amino acids in α2 of CBS2 predicted to interact with F559 
in the R-helix linker or α1 amino acids give rise to CLH-3a-like gating.  A. 
Activation voltage.  B. Activation by bath acidification.  C. Current activation by 
depolarized holding potentials.  D. Effect of holding potential on current 
inactivation.  Data in C and D were acquired as described in Figure 14 legend.  
Values are means ± S.E. (n=5-8).  
 84 
Discussion 
The CBS domain is a highly conserved motif found in diverse proteins including 
channels, transporters, kinases and metabolic enzymes of archeabacteria, eubacteria and 
eukaryotes (Bateman, 1997; Ignoul et al., 2005).  Mutations in CBS domains cause 
diverse inherited diseases such as cardiomyopathy, homocystinuria, retinitis pigmentosa, 
osteopetrosis, and myotonia (e.g., (Pusch, 2002; Ignoul and Eggermont, 2005; Sasaki et 
al., 1999)).  The precise function of CBS domains, however, is poorly understood (Ignoul 
et al., 2005).   
 CBS domains have been crystallized in a variety of proteins (e.g., (Hattori et al., 
2007; Zhang et al., 1999; Rudolph et al., 2007; Miller et al., 2004)) including CLCs 
(Markovic et al., 2007; Meyer et al., 2007; Meyer et al., 2006).  CBS domains are 
typically present in groups of two or four.  The two CBS domains, CBS1 and CBS2, may 
dimerize with another CBS domain pair, to form quaternary structure groups of four CBS 
domains.  CBS1 and CBS2 always interface at the β strands β2 and β3.  In the two 
crystallized CLC CBS domain dimers, the cytoplasmic CBS domain pairs interact at 
CBS2, as shown in the CLH-3b homology model (Figure 9).   
Large deletion mutations in either CBS1 or CBS2 are expected to dramatically 
disrupt CBS domain tertiary structure and this in turn likely disrupts oligomerization.  For 
instance, deletion of the last 17 amino acids of CBS2, which encompass α2 and β3, 
would be expected to disrupt pairing of CBS1 and CBS2 occurring at the β strands.  Our 
results demonstrate that disruption of CLH-3b CBS domain structure (Figure 2 and 
(Denton et al., 2006; He et al., 2006)) gives rise to channels with CLH-3a-like 
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biophysical properties while disruption of CLH-3a CBS structure has little effect on 
channel gating (Figure 15).  These findings indicate 1) that the overall CBS domain 
architecture of CLH-3b plays a critical role in determining the functional properties of the 
channel and 2) that CLH-3a gating appears to be largely insensitive to changes in CBS 
domain conformation.   
The C-terminal end of CBS2 is alternatively spliced in CLH-3a and CLH-3b 
(Figure 13).  This spliced region forms the second α-helix domain, α2.  Splice variation is 
predicted to alter secondary structure and result in α2 in CLH-3b being longer than that of 
CLH-3a (Figure 11).  Consistent with this, we found that insertion of the last six amino 
acids of the CLH-3a CBS2 domain (i.e., VCFLIS) into CLH-3b CBS2 gives rise to CLH-
3a-like voltage- and pH-sensitivity (Figure 16).  Inserting the analogous six amino acids 
of CLH-3b (i.e., LRLAIE) into CLH-3a had little effect on activation voltage or pH 
sensitivity and had an inconsistent effect on sensitivity to depolarized holding potentials.  
However, when the nine alternatively spliced amino acids comprising the longer α2 of 
CLH-3b (i.e., LRLAIEYLQ) were inserted into CLH-3a, the mutant channels were fully 
insensitive to depolarized voltages (Figures 16C-D).   
Given that large scale disruption of CBS structure by deletion mutations has no 
effect on CLH-3a gating, we suggest that splice variation of α2 in CBS2 of this channel 
disrupts critical interactions between CBS domains and other regions within the C-
terminus.  The absence of these interactions gives rise to the gating characteristics of 
CLH-3a.  In contrast, both the primary sequence and predicted altered secondary 
structure of CLH-3b α2 mediate important functional interactions.  Disruption of these 
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interactions by mutation of either CBS1 or CBS2 gives rise to channels with CLH-3a-like 
properties.   
It is important to note that the CLH-3a+LRLAIEYLQ chimeric channel did not 
fully recapitulate CLH-3b gating.  Activation voltage and pH sensitivity of this chimera 
resembled those of wild type CLH-3a (Figures 16A-B).  These results indicate that other 
cytoplasmic domains unique to CLH-3b play a role in determining these gating 
characteristics.  Our previous studies have shown that deletion of the 101 amino acid 
linker domain between CBS1 and CBS2 in CLH-3b (Figure 1) gives rise to channels with 
a strongly hyperpolarized activation voltage (He et al., 2006).  In addition, deletion of the 
160 amino acids immediately C-terminal to LRLAIEYLQ (Figure 13), as in the mutant 
CLH-3b∆842-1001, increases pH sensitivity and hyperpolarizes channel activation 
voltage.   
The molecular mechanisms by which cytoplasmic structures and intracellular 
signaling events regulate CLC channel/transporter function are poorly understood.  
Dutzler and colleagues have suggested that the membrane-associated R-helix may play 
an important role in this regulation (Dutzler et al., 2002).  By virtue of its direct 
connection to the large cytoplasmic C-terminus, the R-helix may provide a pathway by 
which conformational changes in intracellular domains induce rearrangements of the pore 
that in turn alter channel/transporter activity.   
As discussed in chapter II, a short cytoplasmic linker connects the R-helix to 
CBS1.  This R-helix linker lies close to α2 of CBS2 in crystal structures of ClC-0, ClC-5 
and CLC-Ka (Markovic et al., 2007; Meyer et al., 2006; Meyer et al., 2007).  Our 
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homology models of CLH-3a and CLH-3b suggested that potential interactions between 
α2 amino acids and an R-helix linker phenylalanine residue that could be altered by 
splice variation.  Consistent with this, we found that mutation of CLH-3b F559 to 
aspartate or mutation of a predicted interacting alanine residue in α2, A836, gave rise to 
channels with gating properties fully recapitulating those of CLH-3a (Figures 18-19).  In 
contrast, mutation of the analogous R-helix linker phenylalanine residue in CLH-3a had 
no effect on channel activity.   
It should not be overlooked that mutating the predicted interfacing alanine to 
aspartate, A836D, only partially induced CLH-3a like gating, and A836F did not affect 
gating.  The absence of effect of the phenylalanine is consistent with the hydrophobic 
nature predicted for the putative interface between the R-Helix linker and α2.  However, 
it is not supported by the predictions on protein stability that suggest A836F may lead to 
steric repulsions and change of backbone conformation (Chapter II).  Nonetheless, such 
calculations need further refinement before comparison with experimental data.  
There are two hypotheses for why CLH-3b A836D had an incomplete effect on 
channel gating.  First, both bulk and charge may be necessary to break the predicted 
A836-F559 interface.  That is, A836D may only be weakening or altering the predicted 
interface.  Second, there may be other interactions, in conjunction with the proposed α2-
R Helix linker interface, that are necessary for CBS domains to regulate gating.  This 
hypothesis is consistent with the need for proper overall CBS domain configuration to 
maintain CLH-3b like gating.  The hypothesis is also consistent with the data from CLH-
3a+ LRLAIEYLQ, which shows a need for the entire CLH-3b helix to reconstitute CLH-
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3b like gating in CLH-3a.  This hypothesis would also be strengthened if CLH-
3a+LRLAIE A836D gave rise to gating completely resembling that of CLH-3a.  
Regardless of other interactions, mutating both sides of the predicted R Helix linker - α2 
interface did create gating more closely resembling CLH-3a, while mutating several 
nearby amino acids did not.  These data strengthen the proposition that the interface is 
specific to A836 and F559.   
Our data are consistent with a physical interaction between amino acid residues in 
α2 of CBS2 and the R-helix linker, as observed in crystal structures (Markovic et al., 
2007; Meyer et al., 2006; Meyer et al., 2007) and our model.  This interaction could be 
important for determining the conformation of the R-helix and other associated regions 
that control channel gating.  We propose that splice variation of α2 in CLH-3a may be 
disrupting its ability to interact with the R-helix linker, giving rise to the channel’s unique 
gating characteristics.  Mutation of CBS1, CBS2 or the R-helix linker of CLH-3b could 
also disrupt this interaction, giving rise to CLH-3a-like voltage- and pH sensitivity. 
 
 
Closing Remarks 
In summary, our studies provide unique insights into the functional roles of CLC 
CBS domains and the R-helix linker in regulating channel properties.  Our results clearly 
demonstrate a role of CBS2 splice variation in regulating CLH-3a and CLH-3b channel 
gating.  We postulate that the R-helix linker via its interaction with CBS2 provides a 
pathway by which C-terminus conformational changes can modulate the conformation of 
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the R-helix and associated structures and lead to changes in channel function.  Measuring 
solvent accessibility of the channel gate can provide a quick assessment of whether the 
channel gate conformation changes in response to the mutations studied.  Ultimately, 
structural and biochemical studies will be needed to directly test for the postulated 
interaction and to determine the role played by the R-helix linker in mediating the 
regulation of CLC channels and transporters by intracellular signaling events such as 
phosphorylation (e.g., (Falin et al., 2009; Denton et al., 2005) and ATP binding (e.g., (De 
Angeli et al., 2009; Zifarelli and Pusch, 2009b).     
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CHAPTER IV 
 
 
CYSTEINE ACCESSIBILITY, AN ASSESSMENT OF EXTRACELLULAR 
CONFORMATION, IS SIMILAR FOR CLH-3a AND THE R-HELIX LINKER 
MUTANT WITH CLH-3a LIKE GATING 
 
 
Summary 
 Experiments assessing solvent accessibility of extracellular cysteine residues can 
be used to understand protein conformational changes near an introduced cysteine that 
result from mutations.  In the method, Methyl ThioSulfonate (MTS) reagents are applied 
extracellularly and function is assayed.  A different functional response to MTS reagents 
indicates a different solvent accessibility, and thus conformation, of the extracellular 
cysteines in a protein.  Using this method, we found MTSET inhibits channel function in 
a similar manner for CLH-3a and the R-Helix linker mutant with similar gating, CLH-3b 
F559D.  This inhibition is drastically faster than MTSET inhibition of CLH-3b.  All 
channels studied had a cysteine introduced at the channel gate.  These finding are 
consistent with the conformation at the channel gate being similar for CLH-3a and CLH-
3b F559D, but different for CLH-3b. 
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Introduction  
Cysteine accessibility experiments can detect presence of conformational changes 
 Assessing “accessibility” of a residue can be used to detect conformational 
changes at the residue.  A residue is considered accessible to solvent, or a solute, if the 
extracellular solvent or solute molecules contact the residue.  The accessibility of a 
residue can change if the protein conformation near the residue changes.   
Methyl Thiosulfonate (MTS) reagents are commonly used as the solute molecule 
to detect changes in accessibility of cysteine residues.  This is because the MTS reagents 
react with accessible cysteines and this reaction can alter channel function.   The 
Substituted Cysteine Accessibility Method (SCAM) (Karlin and Akabas, 1998) involves 
applying extracellular MTS reagents and assessing change in protein function.  Often 
cysteines are engineered at points of interest and native cysteines are mutated to alanine.  
We use a MTS reagent called MTSET to detect change in accessibility of a cysteine 
placed at the glutamate gate of CLH-3a, CLH-3b, or mutant channels.  This allows us to 
detect change in conformation of the glutamate gate in response to the mutations.   
 
 
SCAM typically involves mutating native cysteines & quantitative functional assays 
  Extracellular MTS reagents can covalently and irreversibly bind to solvent 
accessible SH groups, found in cysteines, by the following reaction: 
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The chemical modification of the cysteine would likely change channel function if the 
cysteine is at a functionally important part of the protein.  In cysteine accessibility 
experiments, MTS reagents react with all solvent accessible cysteine reagents on the side 
of the membrane the reagent is applied.  Thus, native cysteines are typically mutated, 
although information on conformational changes can be inferred even without such 
mutations.   
SCAM experiments are often done on ion channels because of the easy and 
quantitative functional assay available, i.e.  electrophysiology.  Functional response to 
MTS reagents could be a change in current magnitude or change in the rate of change of 
current magnitude in response to a MTS reagent.  A change in function due to MTS 
reagents can be due to a change in accessibility of cysteines, as well as a change in one or 
more of at least three other factors: dissociation rate of the cysteine SH group, steric 
constraints on binding of MTS reagents to cysteines, and the electric field around the 
cysteine residue (Karlin and Akabas, 1998).  Dissociation of the SH group can prevent 
disulfide bond formation between MTS reagents and cysteines.  Steric constraints could 
prevent or slow MTS reagents binding to cysteines, even if the cysteine is accessible to 
solvent.  Electric field near the cysteine residue can impact the binding of charged MTS 
reagents to cysteines.   
A plethora of available MTS reagents allows for using accessibility to infer many 
different structural properties of a protein.  MTS reagents can be used to determine the 
size of solvent pockets in a channel, assess changes in structure due to activation, locate 
channel gates and selectivity filters, and map electrostatic potential (Karlin and Akabas, 
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1998).  MTS reagents with R groups of known and extended length, or flexible R groups, 
can be particularly useful for assessing channel size or measuring distances between 
residues.  One such study has been done to assess voltage-dependent conformational 
changes in the Shaker K+ channel (Darman et al., 2006).  Similar studies have been done 
with non-sulfhydryl long-chain pharmacological compounds that bind channels 
(Blaustein et al., 2000).  Studies of this nature, however, are still few and limited.   
 
 
Previous studies show CLH-3b deletion mutants have gating and inhibition by 
MTSET resembling CLH-3a   
Experiments done in our lab use the reagent MTSET to assess change in 
extracellular conformation.  Native cysteines are maintained and another cysteine is 
introduced at the glutamate gate.  Native cysteines are maintained because CLH-3b with 
all eleven cysteines mutated to alanine (CLH-3b 11CA) has current magnitudes too small 
for accurate analysis, although the kinetics looked similar by eye inspection.  The 
functional assay we use is the change in rate of current inhibition, i.e.  time constant for 
inhibition, in response to MTSET.   
Previous work in our lab by He et al. identified deletion mutations that introduced 
CLH-3a like gating in CLH-3b and also induced CLH-3a like response to MTSET.  
These mutants are CLH-3b ∆833-1001, which deletes the last six amino acids of CBS2 
and the C-terminal tail, and CLH-3b ∆604-614, which deletes the last 11 amino acids of 
CBS1 (He et al., 2006).  CLH-3a and CLH-3b have similar time constants (tau ~ 25 sec) 
for inhibition by MTSET (He et al., 2006).  However, when a cysteine is introduced at 
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the channel gate (CLH-3b E167C and CLH-3a E238C), only the time constant for CLH-
3b drastically increases (tau ~150 sec) (He et al., 2006).  The CLH-3b deletion mutants 
which also have a mutated glutamate gate have a time constant of inhibition similar to 
CLH-3a E238C (He et al., 2006).  This observation lends support to the hypothesis that 
the extracellular conformation of CLH-3a is similar to that of the CLH-3b deletion 
mutants with gating resembling CLH-3a. 
 
 
Is the extracellular conformation of CLH-3b F559D similar to that of CLH-3a? 
We identified a point mutation, F559D, in the R-Helix linker of CLH-3b that 
creates gating resembling CLH-3a (Figure 18).  Similar to previous studies, we tested the 
hypothesis that CLH-3b F559D / E167C, the R-Helix linker and glutamate gate 
mutant, has an extracellular conformation different from that CLH-3b E167C.  We 
also attempted to test the same hypothesis for the same two plasmids with all the native 
cysteines mutated to alanine: CLH-3b F559D / E167C 11CA and CLH-3b E167C 11CA.   
 
 
Methods  
MTSET preparation 
1 mM MTSET ([2-(Trimethylammonium)ethyl] methanethiosulfonate bromide) 
working solutions were used.  40 uL stocks at 40mM were made in water and stored at –
80 deg C.   37.5 uL of stocks were dissolved in 15 mL of bath solution immediately 
before experiments.  MTSET solution was used for up to 1.5 hrs after preparation.   
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Electrophysiology 
Cells were transfected with 5-8ug of plasmids, as described in methods for 
chapter III.  Whole cell electrophysiology was used to assess channel currents, using 
solutions described in methods of chapter III.   
The following protocol was used for an MTSET recording after achieving whole 
cell configuration.  First, with normal bath solution, we ran at least one minute of voltage 
steps to –100 mV, with each step lasting one second in duration.  Current was observed, 
but not recorded.  If the current stabilized, and there were no signs of cell swelling or 
shrinkage, normal bath solution was perfused while continuing to monitor response to –
100 mV steps.  Once current magnitude stabilized with perfusion, recording in response 
to the –100mV voltage steps was initiated, while continuing perfusion.  Five seconds 
after the start of recording, we changed the perfusion to normal bath supplemented with 1 
mM MTSET.  Perfusion with MTSET supplemented bath solution alone was continued 
for twenty seconds, after which perfusion was stopped and recording continued until 
current magnitude stabilized.  Periodically through the recording, the seal was checked.  
If the seal dropped below 1G ohm or if the cell started to swell or shrink, the recording 
was stopped.  Once MTSET was applied to a dish of cells, no new cells were patched. 
 
 
Analysis 
 Current magnitude within a single trace was independent of time.  Current 
magnitude was averaged over 100msec for each trace.  The averages were plotted against 
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time from application of MTSET, and fit with a single exponential function using Origin 
7.0.  The time constant of the exponential function was reported.   
 
 
Results 
To determine whether the CLH-3b F559D R-Helix linker mutation alters the 
conformation of CLH-3b extracellular domains, we mutated the glutamate residue that 
functions as the fast gate to cysteine (i.e., CLH-3b E167C).  Consistent with our previous 
observations (He et al., 2006), this mutation gave rise to constitutively active channels 
that are no longer sensitive to voltage.   
Exposure of the CLH-3b E167C mutant to 1 mM MTSET inhibited whole cell 
current amplitude in a manner similar to our previous report (He et al., 2006).  The mean 
± S.E.  time constant for inhibition was 283 ± 34 sec (n=6).  An additional mutation of 
F559 to aspartate (CLH-3b E167C F559D) reduced the inhibition time constant nearly 7-
fold to a mean ± S.E.  value of 41 ± 6.6 sec (n=5) (Figure 20).  The striking difference in 
rates of MTSET inhibition for E167C and the E167C/F559D double mutant is 
remarkably similar to the difference observed between CLH-3a and CLH-3b (He et al., 
2006).  These data demonstrate that mutation of a single amino acid in the R-helix linker, 
F559, to aspartate converts CLH-3b extracellular cysteine reactivity to those resembling 
CLH-3a. 
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Figure 20: An R Helix linker mutant that has CLH-3a like gating also has CLH-3a like 
time constants for MTSET inhibition. Effect of 1mM MTSET on CLH-3b E167C and 
CLH-3b E167C / F559D (n=5-6). 
 
 
 
Discussion 
 The SCAM method was invented in 1992 (Akabas et al., 1994; Akabas et al., 
1992) by Akabas and colleagues, who provide a comprehensive review (Karlin and 
Akabas, 1998) of the method and its applications.  Cysteine accessibility studies in CLCs 
have largely focused on the channel pore.  Using the method, Chen and colleagues have 
determined the positive charge nature of the pore (Zhang et al., 2006; Zhang et al., 2010).  
They have also explored the effects of oxidation and reduction in CLC-0 (Li et al., 2005).  
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Cysteine accessibility studies have also provided evidence for the conservation of the 
intracellular pore region structure (Engh and Maduke, 2005) and fast gate location (Lin 
and Chen, 2003) between prokaryotic and eukaryotic CLCs.  Our lab has previously used 
cysteine accessibility studies to provide support for intracellular mutations changing the 
conformation at the CLH-3b channel gate (He et al., 2006).   
Our current results show that an R-helix linker mutation, F559D dramatically 
speeds up the rate of inhibition by MTSET of CLH-3b E167C, in a manner similar to the 
faster inhibition seen in CLH-3a (Figure 20).  This suggests that F559D changes the 
extracellular conformation of the channel, and the data is consistent with the new 
conformation being similar to that seen in CLH-3a.   
Unlike many cysteine accessibility studies, we retained native CLH-3b cysteines 
in these experiments due to the extremely small currents of the cysteine-less channel.  
Thus, the effect of MTSET could be due to inhibition at any of CLH-3b’s extracellular 
cysteines.  More information about conformation changes at only the glutamate gate 
could be gained from CLH-3b E167 10CA, which has only 10 of the 11 cysteines 
replaced with alanines and has normal current magnitudes.  If experimental methods 
could be modified to produce larger currents for the CLH-3b 11CA E167C mutant, this 
would provide the ideal mutant for assessing conformation changes at just the channel 
gate.   
Further similar cysteine accessibility experiments can be quite insightful.  Using 
the mutants CLH-3b + VCFLIS E167C and CLH-3a + LRLAIEYLQ E238C, we could 
test if the conformation change due to splice variation could be similar to the change due 
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to mutation of the R Helix linker.  The mutant CLH-3b + RKK demonstrated CLH-3b 
like gating in all manners except activation voltage (chapter III).  Thus similar cysteine 
accessibility studies on CLH-3b+RKK can compare conformational changes that regulate 
activation voltage with those that regulate other gating properties.  Our current, and such 
future, cysteine accessibility experiments, however, provide information on only the 
existence of conformational changes, not their nature.   
Cysteine accessibility experiments have great potential for measuring residue 
distances and provide a more detailed assessment of conformational changes due to 
mutations.  Specifically, one would use MTS compounds with long R group chains, and 
one sulfyhydrl group at each end of the chain to crosslink cysteines in the channel.  
Crosslinking would only occur if the length of the MTS compound was comparable to the 
distance between the cysteines.  Thus, a combination of MTS compounds with R groups 
of various lengths can be used to measure distances between cysteines.  Flexible long 
chain MTS compounds (Darman et al., 2006) could provide a tool that can provide a 
more efficient tool that detects whether cysteines are at a certain length or closer.  While 
sulfhydryl reagents have great promise for measuring distances, such methods can be 
time consuming and have yet to become established procedures.   
Biochemical methods, such as EPR, FRET, and crystallography provide a more 
direct assessment of conformational changes.  Given the minimal functional effect of 
removing native CLH-3b cysteines, EPR could prove very useful.  Such future studies are 
discussed in Chapter V. 
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Closing remarks 
Our results show that the time constant for MTSET inhibition, like channel 
gating, is similar in CLH-3b F559D and CLH-3a, but different from that of CLH-3b.  
This data is consistent with the F559D R Helix linker mutant having an extracellular 
conformation similar to that CLH-3a.  While these findings are very interesting, future 
biochemical experiments are needed to make definitive conclusions regarding changes in 
protein structure due to mutations.   
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CHAPTER V 
 
 
CONCLUSION 
 
 
Background and Summary 
CLC chloride channels mediate a variety of essential cellular functions and 
mutations in CLCs give rise to muscle, kidney, and bone diseases  (Jentsch, 2008).  Some 
of these mutations are in the large intracellular tail of CLCs, including in the 
Cystathionie-β-Synthase domains (Lin et al., 2006; Lloyd et al., 1997).  Thus, a central 
question in the field is how the intracellular portion of CLCs regulate channel function.   
We have made used of the clh-3 encoded C.  elegans splice variants to address 
this question.  Initial studies began in our lab using C. elegans because of the ease of 
studying osmotic stress (Strange, 2007) and performing RNAi in these nematodes 
(Mellouli et al., 2002), which identified the gene underlying a swelling-activated current.  
This gene, clh-3, encodes the splice variants CLH-3a and CLH-3b (He et al., 2006); 
(Denton et al., 2004) which have unique properties that make them ideal for structure-
function studies.  These properties are the localized differences in sequence (Denton et 
al., 2004) inherent with splice variants and the clear and discrete gating differences 
between CLH-3a and CLH-3b (He et al., 2006).  Discreteness means that mutations to the 
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cytoplasmic portion of CLH-3a and CLH-3b generally give rise to channels with gating 
resembling one of the two splice variants (He et al., 2006).  This discreteness may be due 
to gating differences between CLH-3a and CLH-3b originating from a small localized 
region of the channel.   
Indeed, my studies have identified this small region to be nine consecutive amino 
acids near the C-terminus of the last CBS domain (CBS2).  Specifically, interchanging 
these amino acids between CLH-3a and CLH-3b interchanges the channel gating.  I have 
advanced the understanding of mechanisms for this modulation by utilizing homology 
modeling, model driven mutagenesis, and electrophysiology.   
Our models show that these nine amino acids include part of the last alpha helix 
(α2) of CBS2, and predict that this alpha helix is 1-2 amino acids longer in CLH-3b than 
in CLH-3a.  Using the model, I have predicted a possible interaction between A836 of α2 
and F559 of the R Helix linker in CLH-3b.   
Mutagenesis and electrophysiology reveal that mutation of either of these amino 
acids, A836K or F559D, converts gating of CLH-3b to that of CLH-3a.  This 
demonstrates that α2 and the R helix linker both modulate channel gating and that they 
could interface, as predicted.  There is only one other study (Martinez and Maduke, 2008) 
demonstrating that the R Helix linker regulates gating, and our study is the first that 
predicts the R helix linkers interface with functionally important regions of CBS 
domains.  In short, this study presents a novel mechanisms by which CBS domains could 
regulate CLC gating.  Future studies would be very beneficial for conclusively 
demonstrating this suggested role of the R Helix linker.   
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Future Directions 
Conservation of the predicted R Helix linker – α2 interface 
Interestingly, there is significant conservation of our proposed interaction between 
F559 in the R Helix linker and A836 in α2.  F559 is conserved as a bulky hydrophobic 
amino acid in each family member of human CLCs, and A836 is conserved in CLC 
channels, but not transporters.  Thus, one could hypothesize that there may be a 
mechanism shared among CLC channels where the R Helix linker may play a critical role 
in communicating information about the conformation of cytoplasmic C-terminus to 
intramembrane and extracellular regions.  To test this, one would separately mutate to 
lysine or aspartate homologs of A836 and F559 in various CLCs.  If these two mutations 
had similar effects on gating, there may be an interaction between the homologs of A836 
and F559 that regulates channel gating. 
 Within CLH-3b, F559 may regulate gating changes due to cytoplasmic events 
besides α2 splice variation.  Such events include phosphorylation via GCK-3 of the 
intracellular 101 amino acid regulatory domain (Figure 2), which mediates CLH-3b’s 
volume sensitivity (Falin et al., 2009; Denton et al., 2005).  If F559 mediated 
phosphorylation’s effect on gating, F559D would likely alter sensitivity to cell swelling 
or GCK-3 phosphorylation (see introduction).  Both these experiments regarding 
conservation could provide support for a role of the R helix linker’s in transmitting 
various cytoplasmic conformational changes to the channel gate. 
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Is there a biochemical interaction between α2 and the R helix linker? 
An essential follow up is to conclusively test for the predicted F559 - A836 
interaction.  The seemingly easiest approach is to mutate F559 and A836 to Cysteine, 
record gating, crosslink via oxidation, and rerecord gating.  If the cysteine mutations 
changes gating and oxidation restores WT gating, one would conclude there is a 
physiological interaction.  However, given that F559A and A836F have WT gating 
(unpublished preliminary data), F559C and A836C may also have WT gating.  In that 
case, such experiments would be inconclusive.   
As such, biochemical methods are needed.  For instance, CLH-3b F559C/A836C 
could be split between the two CBS domains, oxidized to induce crosslinking, and run on 
a denaturing western.  With that split location, the CBS1-CBS2 non-covalent interactions 
(Markovic and Dutzler, 2007; Meyer et al., 2007; Meyer and Dutzler, 2006) could 
maintain the overall cytoplasmic structure.  The denaturing conditions would later disrupt 
the CBS1-CBS2 interaction, but not the predicted F559C-A836C disulfide bridge.  Thus, 
if the residues interface, the full-length molecular weight would be detected.  Instead of a 
western, Mass Spectrometry, Gel Filtration or Analytical Ultracentrifugation could be 
used to measure molecular weights.   
In another approach, mass spectrometry could detect an interface.  When Mass 
Spectrometry is used for sequencing proteins, the protein is digested into fragments 
whose composition can be determined (Hunt et al., 1986).  Using a similar approach, if a 
fragment from the digested crosslinked cysteine mutant (CLH-3b F559C/A836C) 
contains both A836 and F559, then the residues interface. 
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As a control, each mentioned experiment should be performed on WT CLH-3b or 
CLH-3b with cysteines introduced at other known interaction sites in different 
monomers.  A likely such interaction site is the monomer-monomer interface in α1 of 
CBS2 (Markovic and Dutzler, 2007), which is a leucine in CLC-Ka and the CLH-3b 
model.   
 
 
Electron paramagnetic resonance can assess structural changes due to mutations 
Electron paramagnetic resonance (EPR) can be used, not only to detect 
interactions, but also measure distances between residues (Klug and Feix, 2008), thereby 
elucidating structural information.  Such structural information could identify whether the 
putative F559 – A836 interaction was altered by mutations, but not disrupted.  Proteins 
with two strategically engineering cysteines would be tagged with sulfyhydryl 
compounds that contain one excitable unpaired electron.  The two unpaired electrons, one 
per tag, can influence each other’s excitation in a distance dependent manner, leading to 
distance measurements between the tagged cysteines (Klug and Feix, 2008).   
I would measure distance in WT CLH-3b, WT CLH-3a, and CLH-3b F559D 
cytoplasmic regions.  Two approaches are possible: engineering one cysteine per 
monomer of the homodimer or engineering two cysteines within one monomer and 
coexpressing with excess amounts of a cysteine-less monomer.  The second method 
would allow more direct measurement of distances of our interest.  However, I would 
consider it less favorable since it would entail synthesis of high amounts of protein and 
analysis could be complicated by the possibility of a four-cysteine complex.   
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Strategic placement of the cysteine residues is critical.  Using one cysteine per 
monomer, I would engineer cysteines in four general locations: the outer surface of CBS1 
(α1 or α2) and CBS2 α2, and the R Helix linker near F559 and near the ends of its rigid 
portion.  Using cysteines in only monomer, I would engineer cysteines nearby to F559 
and at either α2 of CBS2, another rigid part of the R Helix linker, or residues spread 
throughout the cytoplasmic region.   
 
 
Do cytoplasmic mutations affect the conformation of the R helix? 
An important question in the field is whether cytoplasmic CLC mutations affect 
the conformation of the R Helix, not just the R Helix linker.  Such experiments would 
require synthesizing full length CLCs, which include the membrane region.  Thus, using 
EPR and X-ray Crystallography to address this question would be challenging.   
Computational studies involving docking the cytoplasmic and membrane regions 
may allow us to predict whether the R Helix interacts non-covalently with the R Helix 
linker or CBS2.  If there is a predicted interface, then model-driven mutations and 
functional assays may shed light on the possibility of the R Helix transmitting functional 
information from the cytoplasmic region to the gate.  Such models, however, must be 
interpreted with caution.   
Cysteine accessibility experiments, such as those we used to assess extracellular 
conformational changes, could theoretically be used.  The R helix, however, is exposed to 
the intracellular region, and as such would require membrane permeable sulfhydryl 
reagents or use of inside-out patch, which has been published in CLC-0 (Pusch et al., 
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1997; Zifarelli et al., 2008), CLC-1 (Liantonio et al., 2003), a likely ortholog of CLC-2 
(Ugarte et al., 2005), CLC-5 (Zifarelli and Pusch, 2009b), and renal Cl- channels (Nissant 
et al., 2006; Lourdel et al., 2003), but not in the low conductance CLH-3b.  CLC-0 to 2, 
as such, may make better model systems where the function altering R Helix linker 
mutation, F559D, is semi-conserved.  Nonetheless, cysteine accessibility experiments 
have not been carried out with inside out-patch in CLCs, likely due to the low current 
magnitude nature of inside-out patch.  The membrane permeable reagents may prove 
useful; however kinetics of inhibition cannot be accurately observed with these reagents.   
Thus, it remains challenging and important to address whether cytoplasmic 
mutations, such as splice variation or R helix linker mutations, affect conformation of the 
R Helix.  Such studies would be greatly enhanced by structural studies on full length 
protein or fast acting membrane permeable sulfhydryl reagents. 
 
 
Closing Remarks 
My studies have made significant headway into understanding how 
Cystathionine-β-Synthase domains regulate CLC channel gating.  In particular, my 
studies demonstrate that interchanging α2 of CBS2 in the splice variants interchanges 
their gating properties.  Moreover, mutation of predicted interacting residues in α2 and 
the R Helix linker also induces CLH-3a like gating in CLH-3b.  This is the first study to 
provide support for a possible role of the R Helix linker in CBS domain regulation of 
channel gating.  A role of the R Helix linker, which connects the R Helix to CBS 
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domains, is consistent with the hypothesized importance of the pore-forming R Helix in 
modulation of channel gating (Meyer and Dutzler, 2006; Dutzler et al., 2002).  By 
extension, my studies suggest novel and valuable insights into mechanisms by which 
CBS domains could regulate gating and lead to muscle, kidney, and bone disorders of 
CLC channel function.   
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